Send us a Message
Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Variants Community Projects QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Advanced Search (OLGA)

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term:hepatocellular carcinoma
go back to main search page
Accession:DOID:684 term browser browse the term
Definition:A liver carcinoma that has_material_basis_in undifferentiated hepatocytes and located_in the liver. (DO)
Synonyms:exact_synonym: Childhood Hepatocellular Carcinoma;   HCC;   Hepatocellular Cancer;   Hepatocellular Carcinoma, Childhood Type, Somatic;   LCC;   adult liver cancer;   adult liver cancers;   hepatocellular cancers;   hepatocellular carcinomas;   hepatoma;   hepatomas;   liver cell carcinoma;   liver cell carcinomas
 narrow_synonym: HEPATOBLASTOMA;   HEPATOBLASTOMA CAUSED BY SOMATIC MUTATION;   hepatitis B virus induced hepatocellular carcinoma;   hepatitis C virus induced hepatocellular carcinoma;   hepatitis virus-related hepatocellular carcinoma
 primary_id: MESH:D006528
 alt_id: MIM:114550
 xref: EFO:0000182;   EFO:0000189;   EFO:0008503;   EFO:0008504;   EFO:0008505;   ICD-O:M8170/3;   ICDO:8170/3;   NCI:C129298;   NCI:C24029;   NCI:C3099;   NCI:C38756;   NCI:C60416;   ORDO:88673
For additional species annotation, visit the Alliance of Genome Resources.


show annotations for term's descendants           Sort by:
hepatocellular carcinoma term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G A2m alpha-2-macroglobulin ISO mRNA,protein:increased expression:liver:
CTD Direct Evidence: marker/mechanism		 CTD
RGD		 PMID:15509519 PMID:15509519 RGD:1358261 NCBI chr 6:121,612,920...121,656,197
Ensembl chr 6:121,612,335...121,656,186 		JBrowse link
G A530016L24Rik RIKEN cDNA A530016L24 gene ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr12:112,455,829...112,466,362
Ensembl chr12:112,455,882...112,466,361 		JBrowse link
G Abca1 ATP-binding cassette, sub-family A member 1 severity ISO mRNA:decreased expression:liver (human) RGD PMID:16941710 PMID:30580964 RGD:1598532, RGD:24922199 NCBI chr 4:53,030,789...53,159,988
Ensembl chr 4:53,030,787...53,159,895 		JBrowse link
G Abcb1a ATP-binding cassette, sub-family B member 1A susceptibility ISO CTD Direct Evidence: marker/mechanism
DNA:polymorphism: : c.1465C > T(human)
DNA:polymorphism: :c.3751G>A(human)		 CTD
RGD		 PMID:17510421 PMID:25625052 PMID:23488625 PMID:24175826 RGD:11041138, RGD:14700904, RGD:14700905 NCBI chr 5:8,617,091...8,798,575
Ensembl chr 5:8,710,077...8,798,575 		JBrowse link
G Abcb4 ATP-binding cassette, sub-family B member 4 ISO
IAGP		 CTD Direct Evidence: marker/mechanism
OMIM:114550		 CTD
MouseDO		 PMID:22022477 NCBI chr 5:8,943,614...9,009,226
Ensembl chr 5:8,943,717...9,009,231 		JBrowse link
G Abcc3 ATP-binding cassette, sub-family C member 3 ISO mRNA:increased expression:liver RGD PMID:25842354 RGD:11535155 NCBI chr11:94,234,121...94,283,843
Ensembl chr11:94,234,121...94,283,823 		JBrowse link
G Abce1 ATP-binding cassette, sub-family E member 1 ISO mRNA:increased expression:liver (human) RGD PMID:21932399 RGD:11041873 NCBI chr 8:80,410,071...80,438,369
Ensembl chr 8:80,410,091...80,438,369 		JBrowse link
G Abl1 c-abl oncogene 1, non-receptor tyrosine kinase IMP RGD PMID:32171747 RGD:126907997 NCBI chr 2:31,578,256...31,697,105
Ensembl chr 2:31,578,388...31,694,239 		JBrowse link
G Acaca acetyl-Coenzyme A carboxylase alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147110 NCBI chr11:84,020,461...84,292,477
Ensembl chr11:84,020,498...84,292,477 		JBrowse link
G Ace angiotensin I converting enzyme susceptibility ISO CTD Direct Evidence: therapeutic
DNA:insertion/deletion:intron 16:		 CTD
RGD		 PMID:16328049 PMID:25208933 RGD:11343535 NCBI chr11:105,858,774...105,880,790
Ensembl chr11:105,858,771...105,880,790 		JBrowse link
G Acer3 alkaline ceramidase 3 disease_progression ISO RGD PMID:30097213 RGD:35673325 NCBI chr 7:97,863,015...97,970,415
Ensembl chr 7:97,855,596...97,970,415 		JBrowse link
G Acly ATP citrate lyase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147110 NCBI chr11:100,367,178...100,418,826
Ensembl chr11:100,367,179...100,418,826 		JBrowse link
G Aco2 aconitase 2, mitochondrial ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr15:81,756,664...81,799,338
Ensembl chr15:81,756,510...81,799,334 		JBrowse link
G Acox1 acyl-Coenzyme A oxidase 1, palmitoyl ISO CTD Direct Evidence: marker/mechanism CTD PMID:12771043 PMID:15565109 NCBI chr11:116,062,714...116,089,605
Ensembl chr11:116,062,714...116,089,871 		JBrowse link
G Acsl4 acyl-CoA synthetase long-chain family member 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 NCBI chr  X:141,100,989...141,173,792
Ensembl chr  X:141,100,989...141,173,531 		JBrowse link
G Actb actin, beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 PMID:21472284 NCBI chr 5:142,888,870...142,892,509
Ensembl chr 5:142,888,870...142,892,509 		JBrowse link
G Adamts1 ADAM metallopeptidase with thrombospondin type 1 motif 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19514085 NCBI chr16:85,590,715...85,600,001
Ensembl chr16:85,590,715...85,600,001 		JBrowse link
G Adamts13 ADAM metallopeptidase with thrombospondin type 1 motif 13 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:26,863,363...26,899,638
Ensembl chr 2:26,863,428...26,899,640 		JBrowse link
G Add1 adducin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 NCBI chr 5:34,731,008...34,789,652
Ensembl chr 5:34,731,008...34,789,652 		JBrowse link
G Adgrg7 adhesion G protein-coupled receptor G7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr16:56,544,972...56,616,369
Ensembl chr16:56,544,972...56,616,218 		JBrowse link
G Adh4 alcohol dehydrogenase 4 (class II), pi polypeptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:138,121,217...138,138,444
Ensembl chr 3:138,121,227...138,136,653 		JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing susceptibility ISO DNA:SNP:intron:+276T>G (rs1501299) (human) RGD PMID:23740135 RGD:14401720 NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778 		JBrowse link
G Adra1a adrenergic receptor, alpha 1a ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr14:66,872,705...67,009,549
Ensembl chr14:66,872,700...67,008,617 		JBrowse link
G Adra2b adrenergic receptor, alpha 2b ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:127,205,099...127,209,141
Ensembl chr 2:127,205,128...127,209,141 		JBrowse link
G Afp alpha fetoprotein severity
disease_progression
treatment		 ISO protein:increased expression:serum (human)
associated with hepatitis B
CTD Direct Evidence: marker/mechanism		 CTD
RGD		 PMID:9029167 PMID:15276417 PMID:24012840 PMID:28284560 PMID:32961231 More... RGD:14401581, RGD:126790579, RGD:126790583, RGD:125097525, RGD:152177911 NCBI chr 5:90,638,573...90,656,766
Ensembl chr 5:90,638,596...90,656,766 		JBrowse link
G Aicda activation-induced cytidine deaminase IGI RGD PMID:18997814 RGD:127285629 NCBI chr 6:122,530,768...122,541,139
Ensembl chr 6:122,530,760...122,541,139 		JBrowse link
G Ak3 adenylate kinase 3 ISO protein:decreased expression:liver RGD PMID:17203974 RGD:13842477 NCBI chr19:28,968,715...29,026,122
Ensembl chr19:28,998,233...29,025,361 		JBrowse link
G Akr1a1 aldo-keto reductase family 1, member A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32805337 NCBI chr 4:116,493,707...116,508,871
Ensembl chr 4:116,493,707...116,508,877 		JBrowse link
G Akr1b1 aldo-keto reductase family 1 member B ISO protein:increased expression:liver (human)
protein:increased expression:liver (rat)		 RGD PMID:19422879 PMID:21683810 RGD:8548685, RGD:5509919 NCBI chr 6:34,280,865...34,294,424
Ensembl chr 6:34,279,369...34,294,413 		JBrowse link
G Akr1b10 aldo-keto reductase family 1, member B10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 6:34,361,182...34,373,884
Ensembl chr 6:34,361,153...34,373,885 		JBrowse link
G Akr1c21 aldo-keto reductase family 1, member C21 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr13:4,624,074...4,636,542
Ensembl chr13:4,624,074...4,636,540 		JBrowse link
G Akt1 thymoma viral proto-oncogene 1 treatment ISO CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Hepatocellular cancer		 CTD
ClinVar
RGD		 PMID:17611497 PMID:18256540 PMID:18392055 PMID:18504432 PMID:18611285 More... RGD:151893509, RGD:152177911 NCBI chr12:112,620,260...112,641,266
Ensembl chr12:112,620,255...112,641,318 		JBrowse link
G Akt2 thymoma viral proto-oncogene 2 ISO
IEP		 protein:increased phosphorylation:liver cancer cell (rat)
protein:increased phosphorylation:liver (mouse)		 RGD PMID:19309364 PMID:28100771 RGD:2313299, RGD:127285675 NCBI chr 7:27,290,977...27,340,251
Ensembl chr 7:27,290,977...27,340,251 		JBrowse link
G Alb albumin susceptibility ISO associated with hepatitis C;protein:decreased expression:serum
protein:decreased expression:serum (human)		 RGD PMID:23892757 PMID:29040987 PMID:22392353 RGD:11035269, RGD:14694841, RGD:125097525 NCBI chr 5:90,608,729...90,624,461
Ensembl chr 5:90,608,756...90,624,461 		JBrowse link
G Aldh2 aldehyde dehydrogenase 2, mitochondrial susceptibility
severity
no_association		 ISO associated with alcoholic liver cirrhosis;DNA:missense mutation:cds:p.E487K (human)
DNA:missense mutation:cds, exon 12:p.E487K (human)
associated with hepatitis C:DNA:SNP:exon 12 (human)
protein:decreased expression: liver (human)
mRNA, protein:decreased expression:liver (human)
DNA:missense mutation:cds: (rs671) (human)
associated with hepatitis B;DNA;missense mutation, haplotype:cds: (rs671) (human)
DNA:missense mutation:exon 12: (human)
associated with alcohol use disorder;DNA:missense mutation:cds: (human)		 RGD PMID:25778454 PMID:1916152 PMID:12940444 PMID:26150517 PMID:28027570 More... RGD:11054822, RGD:14696699, RGD:14696778, RGD:14696779, RGD:15036809, RGD:14700899, RGD:15042857, RGD:15042859, RGD:15042862 NCBI chr 5:121,704,090...121,731,887
Ensembl chr 5:121,704,090...121,731,887 		JBrowse link
G Aldh7a1 aldehyde dehydrogenase family 7, member A1 severity ISO mRNA:altered expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr18:56,657,794...56,706,112
Ensembl chr18:56,642,759...56,706,023 		JBrowse link
G Aldoc aldolase C, fructose-bisphosphate ISO mRNA:increased expression:liver RGD PMID:3830170 RGD:2301136 NCBI chr11:78,213,899...78,218,607
Ensembl chr11:78,213,794...78,218,607 		JBrowse link
G Alx4 aristaless-like homeobox 4 ameliorates ISO mRNA, protein:decreased expression:liver RGD PMID:28081728 PMID:31132711 PMID:31132711 RGD:153323329, RGD:153323330, RGD:153323330 NCBI chr 2:93,472,779...93,511,686
Ensembl chr 2:93,472,729...93,511,684 		JBrowse link
G Angptl6 angiopoietin-like 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:20,785,104...20,791,116
Ensembl chr 9:20,785,104...20,791,023 		JBrowse link
G Ank3 ankyrin 3, epithelial IEP protein:decreased expression:liver RGD PMID:26652480 RGD:153344559 NCBI chr10:69,234,608...69,863,266
Ensembl chr10:69,234,603...69,863,268 		JBrowse link
G Anln anillin, actin binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:22,243,305...22,302,132
Ensembl chr 9:22,243,308...22,300,484 		JBrowse link
G Antxr1 anthrax toxin receptor 1 treatment IDA RGD PMID:20650339 RGD:9684932 NCBI chr 6:87,110,835...87,312,757
Ensembl chr 6:87,110,835...87,312,803 		JBrowse link
G Anxa10 annexin A10 disease_progression ISO mRNA:decreased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr 8:62,510,076...62,576,227
Ensembl chr 8:62,510,076...62,576,184 		JBrowse link
G Anxa2 annexin A2 ISO mRNA, protein:increased expression:liver (human) RGD PMID:33675609 RGD:152999436 NCBI chr 9:69,360,978...69,399,074
Ensembl chr 9:69,360,902...69,399,077 		JBrowse link
G Anxa4 annexin A4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 6:86,713,822...86,770,616
Ensembl chr 6:86,713,822...86,770,566 		JBrowse link
G Anxa6 annexin A6 disease_progression ISO associated with tumor vascularization; protein:decreased expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr11:54,869,779...54,924,297
Ensembl chr11:54,869,934...54,924,271 		JBrowse link
G Apc APC, WNT signaling pathway regulator ISO
IAGP		 OMIM:114550
DNA:hypermethylation
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
CTD Direct Evidence: marker/mechanism		 OMIM
MouseDO
ClinVar
CTD
RGD		 PMID:1316610 PMID:8381579 PMID:8381580 PMID:9536098 PMID:9824584 More... RGD:14402050 NCBI chr18:34,353,350...34,455,243
Ensembl chr18:34,353,977...34,455,605 		JBrowse link
G Apcs amyloid P component, serum ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 NCBI chr 1:172,721,528...172,722,516
Ensembl chr 1:172,721,528...172,722,608 		JBrowse link
G Apex1 apurinic/apyrimidinic endonuclease 1 treatment ISO CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:25109342 PMID:33841550 RGD:152998960 NCBI chr14:51,162,406...51,164,645
Ensembl chr14:51,162,425...51,164,596 		JBrowse link
G Apln apelin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr  X:47,114,023...47,123,730
Ensembl chr  X:47,114,023...47,123,730 		JBrowse link
G Apoa1 apolipoprotein A-I disease_progression ISO CTD Direct Evidence: marker/mechanism
protein:decreased expression:plasma (human)
associated with hepatitis B;		 CTD
RGD		 PMID:21472284 PMID:23935864 PMID:31211449 RGD:25671438, RGD:153350082 NCBI chr 9:46,139,928...46,141,767
Ensembl chr 9:46,139,878...46,141,764 		JBrowse link
G Apoa2 apolipoprotein A-II ISO associated with hepatitis B; mRNA:increased expression:liver RGD PMID:31211449 RGD:153350082 NCBI chr 1:171,049,133...171,053,948
Ensembl chr 1:171,052,623...171,053,948 		JBrowse link
G Apoa4 apolipoprotein A-IV disease_progression ISO associated with hepatitis B; RGD PMID:31211449 RGD:153350082 NCBI chr 9:46,152,142...46,154,756
Ensembl chr 9:46,151,994...46,154,757 		JBrowse link
G Apoc1 apolipoprotein C-I disease_progression ISO associated with hepatitis B; RGD PMID:31211449 RGD:153350082 NCBI chr 7:19,423,405...19,426,584
Ensembl chr 7:19,423,406...19,426,585 		JBrowse link
G Apoc2 apolipoprotein C2 ISO associated with hepatitis B; mRNA:increased expression:liver RGD PMID:31211449 RGD:153350082 NCBI chr 7:19,405,504...19,411,866
Ensembl chr 7:19,405,504...19,411,866 		JBrowse link
G Apoc3 apolipoprotein C-III susceptibility
disease_progression		 ISO associated with Chronic Hepatitis B;DNA:SNP: :rs2854116(human)
associated with hepatitis B;		 RGD PMID:27547913 PMID:31211449 RGD:153344620, RGD:153350082 NCBI chr 9:46,144,348...46,146,934
Ensembl chr 9:46,144,231...46,146,934 		JBrowse link
G Apoc4 apolipoprotein C-IV disease_progression ISO associated with hepatitis B; RGD PMID:31211449 RGD:153350082 NCBI chr 7:19,412,009...19,415,385
Ensembl chr 7:19,412,008...19,415,404 		JBrowse link
G Apoe apolipoprotein E IEP protein:increased expression:liver, serum (mouse) RGD PMID:21644509 RGD:6903288 NCBI chr 7:19,430,169...19,434,326
Ensembl chr 7:19,430,034...19,433,113 		JBrowse link
G Apof apolipoprotein F ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:128,104,568...128,107,119
Ensembl chr10:128,103,866...128,106,022 		JBrowse link
G Aprt adenine phosphoribosyl transferase ISO protein:increased activity:hepatoma (rat) RGD PMID:6327016 RGD:5135035 NCBI chr 8:123,301,376...123,303,646
Ensembl chr 8:123,301,374...123,303,648 		JBrowse link
G Ar androgen receptor ISO CTD Direct Evidence: therapeutic CTD PMID:18639551 NCBI chr  X:97,192,363...97,366,824
Ensembl chr  X:97,192,375...97,366,821 		JBrowse link
G Arg1 arginase, liver disease_progression ISO associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) RGD PMID:17210712 PMID:30901224 RGD:4140476, RGD:152995286 NCBI chr10:24,791,105...24,803,368
Ensembl chr10:24,791,119...24,803,382 		JBrowse link
G Arhgap11a Rho GTPase activating protein 11A ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:113,661,837...113,679,006
Ensembl chr 2:113,661,837...113,679,006 		JBrowse link
G Arhgap44 Rho GTPase activating protein 44 exacerbates ISO protein:decreased expression:liver (human) RGD PMID:31136984 RGD:401901276 NCBI chr11:64,892,865...65,053,779
Ensembl chr11:64,892,865...65,053,787 		JBrowse link
G Arhgef39 Rho guanine nucleotide exchange factor 39 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:43,496,139...43,508,747
Ensembl chr 4:43,496,142...43,499,695 		JBrowse link
G Arid1a AT-rich interaction domain 1A treatment
exacerbates		 ISO
IMP		 CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:liver (human)
mRNA, protein:decreased expression:liver (human)
associated with non-alcoholic steatohepatitis
human gene in mouse model		 CTD
RGD		 PMID:22561517 PMID:22634756 PMID:22922871 PMID:26589513 PMID:25975202 More... RGD:125097485, RGD:125097495, RGD:125097519, RGD:11344640, RGD:126790634, RGD:126790634 NCBI chr 4:133,406,319...133,484,682
Ensembl chr 4:133,406,319...133,484,080 		JBrowse link
G Arid1b AT-rich interaction domain 1B ISO CTD Direct Evidence: marker/mechanism CTD PMID:22634756 NCBI chr17:5,044,481...5,397,931
Ensembl chr17:5,044,607...5,397,931 		JBrowse link
G Arid2 AT-rich interaction domain 2 disease_progression
exacerbates		 ISO CTD Direct Evidence: marker/mechanism
associated with hepatitis B;protein:decreased expression:liver		 CTD
RGD		 PMID:21822264 PMID:22634756 PMID:32071245 PMID:27351279 PMID:28498550 More... RGD:150340708, RGD:150340711, RGD:150340712, RGD:150429631 NCBI chr15:96,185,403...96,303,344
Ensembl chr15:96,185,399...96,302,873 		JBrowse link
G Arid3a AT-rich interaction domain 3A ISO CTD Direct Evidence: marker/mechanism CTD PMID:35179300 NCBI chr10:79,762,877...79,790,852
Ensembl chr10:79,762,877...79,790,852 		JBrowse link
G Arrb2 arrestin, beta 2 treatment ISO RGD PMID:33841550 RGD:152998960 NCBI chr11:70,323,051...70,331,654
Ensembl chr11:70,323,461...70,331,654 		JBrowse link
G Asf1b anti-silencing function 1B histone chaperone ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:84,682,323...84,696,824
Ensembl chr 8:84,682,136...84,696,826 		JBrowse link
G Asl argininosuccinate lyase disease_progression ISO associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr 5:130,040,099...130,053,222
Ensembl chr 5:130,040,099...130,058,088 		JBrowse link
G Asns asparagine synthetase ISO protein:increased activity:serum (rat) RGD PMID:10081 RGD:2316006 NCBI chr 6:7,675,169...7,693,209
Ensembl chr 6:7,675,169...7,693,254 		JBrowse link
G Aspm abnormal spindle microtubule assembly disease_progression ISO CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:28284560 PMID:18676753 RGD:13439743 NCBI chr 1:139,381,450...139,421,826
Ensembl chr 1:139,382,510...139,421,829 		JBrowse link
G Ass1 argininosuccinate synthetase 1 disease_progression ISO associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) RGD PMID:12359751 PMID:30901224 RGD:4140479, RGD:152995286 NCBI chr 2:31,360,282...31,410,682
Ensembl chr 2:31,360,219...31,410,684 		JBrowse link
G Atg101 autophagy related 101 disease_progression ISO RGD PMID:35592424 RGD:153350091 NCBI chr15:101,182,182...101,188,855
Ensembl chr15:101,182,153...101,188,826 		JBrowse link
G Atg7 autophagy related 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29191453 NCBI chr 6:114,620,075...114,837,565
Ensembl chr 6:114,620,058...114,837,575 		JBrowse link
G Atm ataxia telangiectasia mutated exacerbates ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:liver (human)		 CTD
RGD		 PMID:12866955 PMID:19919837 RGD:126781750 NCBI chr 9:53,348,422...53,448,125
Ensembl chr 9:53,350,449...53,448,040 		JBrowse link
G Atp5pb ATP synthase peripheral stalk-membrane subunit b ISO associated with hepatitis C RGD PMID:18932288 RGD:14696822 NCBI chr 3:105,850,014...105,866,579
Ensembl chr 3:105,850,014...105,867,415 		JBrowse link
G Atp5pd ATP synthase peripheral stalk subunit d ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr11:115,306,517...115,310,775
Ensembl chr11:115,306,515...115,310,788 		JBrowse link
G Atp7b ATPase, copper transporting, beta polypeptide onset ISO RGD PMID:8291609 RGD:15036817 NCBI chr 8:22,482,799...22,550,347
Ensembl chr 8:22,482,801...22,550,321 		JBrowse link
G Aurkb aurora kinase B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr11:68,936,477...68,942,490
Ensembl chr11:68,936,473...68,942,490 		JBrowse link
G Axin1 axin 1 disease_progression ISO
IMP		 CTD Direct Evidence: marker/mechanism
associated with Hepatitis B, Chronic,DNA:SNP, haplotype:exon:(rs1805105) T>C (human)
protein:decreased expression:liver (human)
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma		 OMIM
CTD
ClinVar
RGD		 PMID:10700176 PMID:25741868 PMID:25822088 PMID:28492532 PMID:37582359 More... RGD:1300371, RGD:14402039, RGD:150530481, RGD:150530482 NCBI chr17:26,350,294...26,414,784
Ensembl chr17:26,357,662...26,414,785 		JBrowse link
G Axin2 axin 2 ISO protein:increased expression:liver: RGD PMID:11809809 RGD:151356508 NCBI chr11:108,808,687...108,841,609
Ensembl chr11:108,811,175...108,841,609 		JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc disease_progression ISO mRNA:decreased expression:liver RGD PMID:22625427 PMID:27993894 PMID:26902423 RGD:153350130, RGD:153350132, RGD:153350133 NCBI chr 5:137,979,783...137,988,495
Ensembl chr 5:137,979,782...137,988,495 		JBrowse link
G Azin1 antizyme inhibitor 1 disease_progression ISO RNA:increased editing:liver RGD PMID:23291631 RGD:14700705 NCBI chr15:38,487,674...38,523,506
Ensembl chr15:38,487,671...38,519,510 		JBrowse link
G Banf1 BAF nuclear assembly factor 1 treatment ISO
IMP		 mRNA, protein:increased expression:liver (rat)
mRNA, protein:increased expression:liver (human)		 RGD PMID:29059470 PMID:29059470 PMID:29059470 RGD:155791679, RGD:155791679, RGD:155791679 NCBI chr19:5,414,661...5,416,904
Ensembl chr19:5,414,666...5,417,196 		JBrowse link
G Bax BCL2-associated X protein treatment ISO RGD PMID:33841550 RGD:152998960 NCBI chr 7:45,111,124...45,116,332
Ensembl chr 7:45,111,121...45,116,322 		JBrowse link
G Bcl2 B cell leukemia/lymphoma 2 treatment IEP
ISO		 mRNA:increased expression:liver (mouse) RGD PMID:28100771 PMID:33841550 RGD:127285675, RGD:152998960 NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004 		JBrowse link
G Bcl2l1 BCL2-like 1 treatment ISO
IEP		 CTD Direct Evidence: marker/mechanism|therapeutic
mRNA:increased expression:liver (mouse)		 CTD
RGD		 PMID:10629087 PMID:11509945 PMID:28100771 PMID:33841550 RGD:127285675, RGD:152998960 NCBI chr 2:152,600,652...152,673,632
Ensembl chr 2:152,622,588...152,673,648 		JBrowse link
G Bco2 beta-carotene oxygenase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:50,444,387...50,466,513
Ensembl chr 9:50,444,387...50,466,481 		JBrowse link
G Bcorl1 BCL6 co-repressor-like 1 disease_progression ISO RGD PMID:29679906 PMID:26879601 RGD:150340705, RGD:11556159 NCBI chr  X:47,430,235...47,496,945
Ensembl chr  X:47,430,235...47,496,926 		JBrowse link
G Bhmt betaine-homocysteine methyltransferase disease_progression ISO associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr13:93,753,399...93,774,266
Ensembl chr13:93,753,183...93,774,469 		JBrowse link
G Bhmt2 betaine-homocysteine methyltransferase 2 severity ISO mRNA:altered expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr13:93,792,605...93,810,810
Ensembl chr13:93,792,228...93,810,810 		JBrowse link
G Bid BH3 interacting domain death agonist ISO CTD Direct Evidence: marker/mechanism CTD PMID:15289866 NCBI chr 6:120,870,080...120,894,074
Ensembl chr 6:120,868,891...120,893,814 		JBrowse link
G Birc3 baculoviral IAP repeat-containing 3 ameliorates
exacerbates
treatment		 ISO human cell line in a mouse model
associated with hepatitis B;mRNA, protein:increased expression:liver (human)		 RGD PMID:30368883 PMID:22682366 PMID:22820591 PMID:33310033 PMID:30210622 RGD:152998937, RGD:152998984, RGD:152998986, RGD:152998988, RGD:152999010 NCBI chr 9:7,848,698...7,873,199
Ensembl chr 9:7,848,700...7,873,187 		JBrowse link
G Birc5 baculoviral IAP repeat-containing 5 disease_progression ISO CTD Direct Evidence: marker/mechanism|therapeutic
mRNA:increased expression:liver (human)		 CTD
RGD		 PMID:16086872 PMID:20514400 PMID:31964418 RGD:153344516 NCBI chr11:117,740,063...117,746,569
Ensembl chr11:117,740,077...117,746,569 		JBrowse link
G Birc7 baculoviral IAP repeat-containing 7 exacerbates ISO mRNA:increased expression:liver (human) RGD PMID:31964418 RGD:153344516 NCBI chr 2:180,570,402...180,575,803
Ensembl chr 2:180,570,816...180,575,803 		JBrowse link
G Blzf1 basic leucine zipper nuclear factor 1 disease_progression ISO RGD PMID:26342799 RGD:14398326 NCBI chr 1:164,117,368...164,135,056
Ensembl chr 1:164,117,369...164,135,058 		JBrowse link
G Bmi1 Bmi1 polycomb ring finger oncogene treatment ISO RGD PMID:26919246 RGD:14928318 NCBI chr 2:18,681,953...18,691,440
Ensembl chr 2:18,681,829...18,691,440 		JBrowse link
G Bmper BMP-binding endothelial regulator ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:23,134,372...23,396,511
Ensembl chr 9:23,134,372...23,396,496 		JBrowse link
G Braf Braf transforming gene ISO CTD Direct Evidence: marker/mechanism CTD PMID:27222248 NCBI chr 6:39,580,171...39,702,592
Ensembl chr 6:39,580,171...39,702,397 		JBrowse link
G Bsg basigin ISO CTD Direct Evidence: marker/mechanism CTD PMID:36574092 NCBI chr10:79,540,192...79,547,813
Ensembl chr10:79,540,325...79,547,803 		JBrowse link
G Btg2 BTG anti-proliferation factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18393292 NCBI chr 1:134,002,603...134,006,893
Ensembl chr 1:134,002,908...134,006,858 		JBrowse link
G Bub1 BUB1, mitotic checkpoint serine/threonine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:127,642,117...127,673,790
Ensembl chr 2:127,643,036...127,673,785 		JBrowse link
G Bub1b BUB1B, mitotic checkpoint serine/threonine kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:118,428,684...118,472,073
Ensembl chr 2:118,428,692...118,472,072 		JBrowse link
G C3 complement component 3 ISO RGD PMID:23245919 RGD:11040806 NCBI chr17:57,510,967...57,535,136
Ensembl chr17:57,510,970...57,535,136 		JBrowse link
G C9 complement component 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 PMID:28284560 NCBI chr15:6,474,827...6,528,306
Ensembl chr15:6,474,808...6,528,232 		JBrowse link
G Cab39 calcium binding protein 39 disease_progression ISO RGD PMID:28605041 PMID:28605041 RGD:14398832, RGD:14398832 NCBI chr 1:85,707,796...85,779,298
Ensembl chr 1:85,721,162...85,779,297 		JBrowse link
G Cad carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase ISO DNA:amplification:cds (rat)
mRNA:increased expression:liver		 RGD PMID:2914957 PMID:2888462 PMID:7053379 RGD:5132587, RGD:2303530, RGD:10755426 NCBI chr 5:31,211,964...31,235,823
Ensembl chr 5:31,212,124...31,235,823 		JBrowse link
G Cadm1 cell adhesion molecule 1 ISO DNA, mRNA, protein:hypermethylation, decreased expression:promoter, liver RGD PMID:17428255 RGD:2289095 NCBI chr 9:47,441,468...47,773,578
Ensembl chr 9:47,441,471...47,769,413 		JBrowse link
G Cadm2 cell adhesion molecule 2 disease_progression ISO mRNA, protein:decreased expression:liver RGD PMID:24240726 RGD:15092075 NCBI chr16:66,452,302...67,417,825
Ensembl chr16:66,452,307...67,417,796 		JBrowse link
G Calml3 calmodulin-like 3 severity ISO protein:decreased expression:liver (human) RGD PMID:29445139 RGD:151665319 NCBI chr13:3,852,893...3,854,318
Ensembl chr13:3,852,896...3,854,316 		JBrowse link
G Calr calreticulin exacerbates
treatment		 ISO protein:increased expression:liver (human)
human cells and recombinant gene in a mouse model		 RGD PMID:27055635 PMID:12096119 PMID:24997628 RGD:150521681, RGD:150521690, RGD:150521691 NCBI chr 8:85,568,717...85,573,560
Ensembl chr 8:85,568,479...85,573,563 		JBrowse link
G Camk2n1 calcium/calmodulin-dependent protein kinase II inhibitor 1 ISO RGD PMID:23651211 RGD:18337283 NCBI chr 4:138,182,459...138,187,437
Ensembl chr 4:138,181,625...138,187,434 		JBrowse link
G Cap2 cyclase associated actin cytoskeleton regulatory protein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr13:46,655,379...46,803,757
Ensembl chr13:46,655,324...46,803,757 		JBrowse link
G Capn3 calpain 3 ISO mRNA:decreased expression:skeletal muscle RGD PMID:10806331 RGD:1600777 NCBI chr 2:120,294,074...120,335,400
Ensembl chr 2:120,294,053...120,335,399 		JBrowse link
G Car12 carbonic anhydrase 12 disease_progression
ameliorates		 ISO
IMP		 mRNA:altered expression:liver RGD PMID:35362480 PMID:35362480 PMID:31934040 PMID:29900055 RGD:153352325, RGD:153352325, RGD:153352328, RGD:155226869 NCBI chr 9:66,619,026...66,674,127
Ensembl chr 9:66,620,968...66,674,127 		JBrowse link
G Car2 carbonic anhydrase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 3:14,951,329...14,965,830
Ensembl chr 3:14,951,333...14,965,830 		JBrowse link
G Car9 carbonic anhydrase 9 ISO mRNA:altered expression:liver RGD PMID:29900055 RGD:155226869 NCBI chr 4:43,507,026...43,513,729
Ensembl chr 4:43,506,966...43,513,729 		JBrowse link
G Carm1 coactivator-associated arginine methyltransferase 1 ISO mRNA,protein:increased expression:liver: RGD PMID:23912631 RGD:9586718 NCBI chr 9:21,458,163...21,500,763
Ensembl chr 9:21,458,190...21,503,919 		JBrowse link
G Casp3 caspase 3 treatment ISO RGD PMID:29133031 PMID:33841550 RGD:13782296, RGD:152998960 NCBI chr 8:47,070,326...47,092,733
Ensembl chr 8:47,070,326...47,092,724 		JBrowse link
G Casp8 caspase 8 treatment
severity		 ISO associated with hepatitis B;DNA:insertion/deletion:promoter: (rs3834129) (human)
CTD Direct Evidence: marker/mechanism		 OMIM
CTD
RGD		 PMID:29133031 PMID:28643196 RGD:13782296, RGD:14695027 NCBI chr 1:58,834,553...58,886,663
Ensembl chr 1:58,834,533...58,886,662 		JBrowse link
G Casp9 caspase 9 treatment ISO RGD PMID:29133031 RGD:13782296 NCBI chr 4:141,520,923...141,543,289
Ensembl chr 4:141,520,923...141,543,287 		JBrowse link
G Cat catalase disease_progression ISO associated with liver cirrhosis with Hepatitis C;DNA:SNP:promoter:-262T>C (human)
CTD Direct Evidence: marker/mechanism		 CTD
RGD		 PMID:33010264 PMID:21907168 RGD:27095879 NCBI chr 2:103,284,249...103,315,498
Ensembl chr 2:103,284,194...103,315,505 		JBrowse link
G Cbfb core binding factor beta ISO mRNA:decreased expression:liver RGD PMID:17094378 RGD:126775147 NCBI chr 8:105,897,306...105,944,621
Ensembl chr 8:105,897,306...105,944,621 		JBrowse link
G Cbl Casitas B-lineage lymphoma disease_progression ISO RGD PMID:26474280 RGD:11536137 NCBI chr 9:44,054,273...44,145,556
Ensembl chr 9:44,054,273...44,145,346 		JBrowse link
G Cbr1 carbonyl reductase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21056497 NCBI chr16:93,404,752...93,407,226
Ensembl chr16:93,402,741...93,407,393 		JBrowse link
G Cbx2 chromobox 2 disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr11:118,913,845...118,922,101
Ensembl chr11:118,913,788...118,922,096 		JBrowse link
G Cbx4 chromobox 4 disease_progression ISO protein:increased expression:cytoplasm: RGD PMID:24838576 PMID:23943028 RGD:9586738, RGD:9586739 NCBI chr11:118,968,399...118,977,067
Ensembl chr11:118,968,399...118,977,047 		JBrowse link
G Cbx7 chromobox 7 ISO mRNA:decreased expression:liver RGD PMID:22041561 RGD:9587355 NCBI chr15:79,800,005...79,855,344
Ensembl chr15:79,800,008...79,855,320 		JBrowse link
G Ccbe1 collagen and calcium binding EGF domains 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr18:66,189,926...66,424,909
Ensembl chr18:66,178,373...66,435,812 		JBrowse link
G Ccl1 C-C motif chemokine ligand 1 IEP mRNA:increased expression:liver (mouse) RGD PMID:26569409 RGD:11344640 NCBI chr11:82,067,492...82,070,638
Ensembl chr11:82,067,483...82,196,516 		JBrowse link
G Ccl12 C-C motif chemokine ligand 12 IEP mRNA:increased expression:liver (mouse) RGD PMID:26569409 RGD:11344640 NCBI chr11:81,992,671...81,994,225
Ensembl chr11:81,992,671...81,994,226 		JBrowse link
G Ccl2 C-C motif chemokine ligand 2 treatment ISO
IMP		 RNA:increased expression:liver RGD PMID:27980102 PMID:27980102 PMID:12679798 PMID:22402625 RGD:14995459, RGD:14995459, RGD:14995468, RGD:14995927 NCBI chr11:81,926,403...81,928,278
Ensembl chr11:81,926,397...81,928,279 		JBrowse link
G Ccl3 C-C motif chemokine ligand 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16284949 NCBI chr11:83,538,669...83,540,204
Ensembl chr11:83,538,670...83,540,181 		JBrowse link
G Ccl5 C-C motif chemokine ligand 5 treatment
susceptibility		 IMP
ISO		 DNA:polymorphisms:promoter:-403G>A,-28C>G (human)
associated with alcoholic liver cirrhosis;DNA:SNP:promoter:-403G>A(human)		 RGD PMID:28011329 PMID:22374185 PMID:21610221 RGD:14995306, RGD:14995333, RGD:14995338 NCBI chr11:83,416,604...83,421,344
Ensembl chr11:83,416,604...83,421,344 		JBrowse link
G Ccl9 C-C motif chemokine ligand 9 IEP mRNA:increased expression:liver (mouse) RGD PMID:26569409 RGD:11344640 NCBI chr11:83,463,743...83,469,462
Ensembl chr11:83,463,745...83,469,462 		JBrowse link
G Ccn1 cellular communication network factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17699798 NCBI chr 3:145,352,726...145,355,740
Ensembl chr 3:145,352,731...145,355,736 		JBrowse link
G Ccna1 cyclin A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12029619 NCBI chr 3:54,952,890...54,965,055
Ensembl chr 3:54,952,890...54,962,922 		JBrowse link
G Ccnb1 cyclin B1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr13:100,915,247...100,922,994
Ensembl chr13:100,915,158...100,923,078 		JBrowse link
G Ccnb2 cyclin B2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:70,314,971...70,328,836
Ensembl chr 9:70,314,974...70,328,829 		JBrowse link
G Ccnd1 cyclin D1 susceptibility ISO
IEP		 associated with Hepatitis B, Chronic;DNA:SNP:splice-site mutation:870G>A (human)
mRNA:increased expression:liver (mouse)		 RGD PMID:25851350 PMID:28100771 RGD:14401586, RGD:127285675 NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662 		JBrowse link
G Ccnd2 cyclin D2 severity
disease_progression
susceptibility		 ISO associated with hepatitis B
DNA:hypermethylation:CpG site
associated with Chronic Hepatitis C;DNA:SNP: :rs1049606(human)		 RGD PMID:33320844 PMID:33320844 PMID:31059558 PMID:22004425 RGD:151664743, RGD:151664743, RGD:151665109, RGD:151665169 NCBI chr 6:127,102,125...127,131,913
Ensembl chr 6:127,102,125...127,129,156 		JBrowse link
G Ccne1 cyclin E1 ameliorates ISO
IEP
IMP		 CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:12029619 PMID:22634754 PMID:17196522 PMID:28100771 PMID:29551768 RGD:2289277, RGD:127285675, RGD:153297807 NCBI chr 7:37,797,409...37,806,915
Ensembl chr 7:37,797,409...37,806,959 		JBrowse link
G Ccnf cyclin F ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr17:24,441,518...24,470,333
Ensembl chr17:24,441,172...24,470,458 		JBrowse link
G Ccng1 cyclin G1 treatment
disease_progression
severity		 ISO
IMP		 protein:increased expression:liver (human)
human cells in mouse model
protein:decreased expression:liver (human)		 RGD PMID:25431954 PMID:24034575 PMID:26345095 PMID:23804702 PMID:23804702 More... RGD:151356922, RGD:151356932, RGD:151356933, RGD:151356967, RGD:151356967, RGD:151356970, RGD:151356981, RGD:151361198, RGD:151361200 NCBI chr11:40,639,379...40,646,044
Ensembl chr11:40,639,379...40,646,138 		JBrowse link
G Ccng2 cyclin G2 IMP RGD PMID:27982046 RGD:151361200 NCBI chr 5:93,415,432...93,424,090
Ensembl chr 5:93,415,116...93,424,090 		JBrowse link
G Ccr1 C-C motif chemokine receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16284949 NCBI chr 9:123,762,163...123,768,729
Ensembl chr 9:123,762,161...123,768,729 		JBrowse link
G Cd163 CD163 antigen ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 6:124,281,596...124,307,488
Ensembl chr 6:124,281,615...124,307,486 		JBrowse link
G Cd209b CD209b antigen ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:3,967,655...3,976,841
Ensembl chr 8:3,967,655...3,976,844 		JBrowse link
G Cd274 CD274 antigen disease_progression ISO CTD Direct Evidence: marker/mechanism
associated with hepatitis B
associated with hepatitis B		 CTD
RGD		 PMID:22396772 PMID:30267213 PMID:21912640 RGD:40818240, RGD:41410800 NCBI chr19:29,339,428...29,365,495
Ensembl chr19:29,344,855...29,365,495 		JBrowse link
G Cd276 CD276 antigen ISO CTD Direct Evidence: therapeutic CTD PMID:16217749 NCBI chr 9:58,431,581...58,463,437
Ensembl chr 9:58,431,581...58,462,720 		JBrowse link
G Cd34 CD34 antigen ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:194,621,239...194,643,587
Ensembl chr 1:194,621,127...194,643,587 		JBrowse link
G Cd40lg CD40 ligand IMP RGD PMID:19016771 RGD:2313413 NCBI chr  X:56,257,448...56,269,402
Ensembl chr  X:56,257,503...56,269,402 		JBrowse link
G Cd5l CD5 antigen-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:87,265,188...87,278,381
Ensembl chr 3:87,265,188...87,278,380 		JBrowse link
G Cd68 CD68 antigen severity ISO protein:increased expression:liver (human) RGD PMID:28656201 RGD:40924686 NCBI chr11:69,555,039...69,556,996
Ensembl chr11:69,555,039...69,556,979 		JBrowse link
G Cdc20 cell division cycle 20 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:118,290,098...118,294,540
Ensembl chr 4:118,290,098...118,294,549 		JBrowse link
G Cdc25c cell division cycle 25C ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr18:34,866,046...34,884,644
Ensembl chr18:34,866,046...34,884,586 		JBrowse link
G Cdc27 cell division cycle 27 ISO ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar NCBI chr11:104,393,350...104,441,371
Ensembl chr11:104,393,571...104,441,446 		JBrowse link
G Cdc45 cell division cycle 45 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr16:18,599,202...18,632,371
Ensembl chr16:18,599,197...18,630,737 		JBrowse link
G Cdc6 cell division cycle 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr11:98,798,627...98,814,768
Ensembl chr11:98,798,627...98,814,766 		JBrowse link
G Cdca5 cell division cycle associated 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr19:6,135,127...6,141,803
Ensembl chr19:6,135,013...6,141,807 		JBrowse link
G Cdca8 cell division cycle associated 8 disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr 4:124,812,258...124,830,710
Ensembl chr 4:124,812,258...124,833,104 		JBrowse link
G Cdh1 cadherin 1 severity ISO
IMP		 DNA:hypermethylation
mRNA:increased expression:liver
protein:decreased expression:liver		 RGD PMID:17295234 PMID:30697077 PMID:30697077 PMID:24840851 PMID:18837082 RGD:2289638, RGD:14402045, RGD:14402045, RGD:14402046, RGD:14402047 NCBI chr 8:107,329,982...107,396,879
Ensembl chr 8:107,329,983...107,396,878 		JBrowse link
G Cdh13 cadherin 13 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18425332 PMID:18553387 PMID:28284560 NCBI chr 8:119,010,150...120,051,668
Ensembl chr 8:119,010,472...120,051,660 		JBrowse link
G Cdk1 cyclin dependent kinase 1 ISO protein:increased expression:liver (human)
CTD Direct Evidence: marker/mechanism		 CTD
RGD		 PMID:28284560 PMID:19136513 RGD:2316317 NCBI chr10:69,170,976...69,188,742
Ensembl chr10:69,170,976...69,188,768 		JBrowse link
G Cdk12 cyclin dependent kinase 12 exacerbates ISO mRNA, protein:increased expression:liver (human) RGD PMID:31519701 RGD:151361172 NCBI chr11:98,093,259...98,171,941
Ensembl chr11:98,093,885...98,169,330 		JBrowse link
G Cdk13 cyclin dependent kinase 13 onset ISO DNA:amplification: : RGD PMID:22912832 RGD:155641228 NCBI chr13:17,885,309...17,979,960
Ensembl chr13:17,884,900...17,979,682 		JBrowse link
G Cdk14 cyclin dependent kinase 14 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22922871 NCBI chr 5:4,853,384...5,430,650
Ensembl chr 5:4,853,391...5,470,312 		JBrowse link
G Cdk4 cyclin dependent kinase 4 treatment ISO CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:26189965 PMID:33841550 RGD:152998960 NCBI chr10:126,899,404...126,903,157
Ensembl chr10:126,899,403...126,903,789 		JBrowse link
G Cdkn1a cyclin dependent kinase inhibitor 1A IAGP OMIM:114550 MouseDO NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701 		JBrowse link
G Cdkn1b cyclin dependent kinase inhibitor 1B ISO CTD Direct Evidence: marker/mechanism CTD PMID:20698225 NCBI chr 6:134,897,364...134,902,488
Ensembl chr 6:134,897,364...134,902,476 		JBrowse link
G Cdkn1c cyclin dependent kinase inhibitor 1C severity ISO protein:decreased expression:liver (human) RGD PMID:26606000 RGD:11354707 NCBI chr 7:143,012,076...143,014,735
Ensembl chr 7:143,012,076...143,014,787 		JBrowse link
G Cdkn2a cyclin dependent kinase inhibitor 2A severity ISO Protein:increased expression:liver
DNA:hypermethylation:promoter
DNA:hypermethylation:exon
Protein:decreased expression:liver
CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA		 RGD
CTD
ClinVar		 PMID:7780957 PMID:8521414 PMID:9185756 PMID:9324288 PMID:10491434 More... RGD:1600816, RGD:1600816, RGD:1600822, RGD:8552680 NCBI chr 4:89,192,710...89,212,856
Ensembl chr 4:89,192,708...89,212,890 		JBrowse link
G Cdkn2b cyclin dependent kinase inhibitor 2B ISO CTD Direct Evidence: marker/mechanism CTD PMID:33010264 NCBI chr 4:89,224,526...89,229,269
Ensembl chr 4:89,224,536...89,229,276 		JBrowse link
G Cdkn2c cyclin dependent kinase inhibitor 2C ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:109,518,073...109,523,953
Ensembl chr 4:109,518,073...109,524,386 		JBrowse link
G Cdkn3 cyclin dependent kinase inhibitor 3 severity
treatment		 ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:liver
protein:decreased expression:liver
associated with alcoholism; protein:increased expression:liver		 CTD
RGD		 PMID:28284560 PMID:22390936 PMID:27314282 PMID:23292002 PMID:23292002 RGD:15090800, RGD:15090801, RGD:15090802, RGD:15090802 NCBI chr14:46,997,912...47,008,987
Ensembl chr14:46,997,998...47,009,126 		JBrowse link
G Cdt1 chromatin licensing and DNA replication factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:123,294,754...123,299,869
Ensembl chr 8:123,294,754...123,300,293 		JBrowse link
G Cebpa CCAAT/enhancer binding protein alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:16288022 PMID:21785164 NCBI chr 7:34,818,718...34,821,353
Ensembl chr 7:34,818,718...34,821,353 		JBrowse link
G Cebpb CCAAT/enhancer binding protein beta ISO CTD Direct Evidence: marker/mechanism
mRNA: increased expression:liver (human)		 CTD
RGD		 PMID:14563831 PMID:30659195 RGD:40903042 NCBI chr 2:167,530,835...167,532,352
Ensembl chr 2:167,530,835...167,532,338 		JBrowse link
G Cebpd CCAAT/enhancer binding protein delta ISO CTD Direct Evidence: marker/mechanism CTD PMID:14563831 NCBI chr16:15,705,150...15,707,409
Ensembl chr16:15,705,150...15,708,895 		JBrowse link
G Celsr3 cadherin, EGF LAG seven-pass G-type receptor 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:108,703,244...108,730,168
Ensembl chr 9:108,703,519...108,730,168 		JBrowse link
G Cenpa centromere protein A ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:liver (human)		 CTD
RGD		 PMID:28284560 PMID:21956590 RGD:36947377 NCBI chr 5:30,824,214...30,832,181
Ensembl chr 5:30,824,121...30,832,174 		JBrowse link
G Cenpe centromere protein E ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:134,918,324...134,979,301
Ensembl chr 3:134,918,298...134,979,372 		JBrowse link
G Cenpf centromere autoantigen F ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:189,372,803...189,420,302
Ensembl chr 1:189,372,803...189,420,283 		JBrowse link
G Cenpm centromere protein M ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr15:82,115,694...82,128,974
Ensembl chr15:82,117,980...82,128,949 		JBrowse link
G Cenpu centromere protein U ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:47,005,054...47,033,603
Ensembl chr 8:47,005,063...47,033,042 		JBrowse link
G Cenpw centromere protein W ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:30,072,005...30,076,599
Ensembl chr10:30,070,565...30,076,556 		JBrowse link
G Cep131 centrosomal protein 131 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr11:119,955,247...119,977,684
Ensembl chr11:119,955,256...119,977,653 		JBrowse link
G Cep164 centrosomal protein 164 susceptibility ISO associated with Chronic Hepatitis C;DNA:SNP: :rs573455 (human) RGD PMID:22004425 RGD:151665169 NCBI chr 9:45,678,244...45,739,984
Ensembl chr 9:45,678,244...45,739,989 		JBrowse link
G Ces1d carboxylesterase 1D disease_progression ISO protein:decreased expression:liver (human)
mRNA, protein:decreased expression:liver tumor (human)
associated with tumor vascularization; protein:decreased expression:liver tumor (human)		 RGD PMID:24259486 PMID:19658107 PMID:30901224 RGD:152995276, RGD:152995279, RGD:152995286 NCBI chr 8:93,892,700...93,924,432
Ensembl chr 8:93,892,696...93,924,466 		JBrowse link
G Cfp complement factor properdin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr  X:20,791,693...20,797,794
Ensembl chr  X:20,791,693...20,797,794 		JBrowse link
G Chaf1b chromatin assembly factor 1, subunit B (p60) ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr16:93,680,801...93,703,003
Ensembl chr16:93,680,789...93,703,003 		JBrowse link
G Chd4 chromodomain helicase DNA binding protein 4 exacerbates ISO mRNA:increased expression:liver (human)
protein:increased expression:liver (human)		 RGD PMID:28486105 PMID:26095183 RGD:153323299, RGD:11571740 NCBI chr 6:125,073,144...125,107,554
Ensembl chr 6:125,072,944...125,107,554 		JBrowse link
G Chd5 chromodomain helicase DNA binding protein 5 ISO mRNA:decreased expression:liver RGD PMID:26517514 RGD:11537550 NCBI chr 4:152,423,103...152,474,651
Ensembl chr 4:152,423,108...152,474,651 		JBrowse link
G Ckap2l cytoskeleton associated protein 2-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:129,110,130...129,139,148
Ensembl chr 2:129,110,130...129,139,132 		JBrowse link
G Ckap4 cytoskeleton-associated protein 4 disease_progression ISO associated with tumor vascularization; mRNA,protein:increased expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr10:84,362,169...84,369,752
Ensembl chr10:84,362,169...84,369,926 		JBrowse link
G Cldn1 claudin 1 severity IEP protein:increased expression:liver (human)
protein:decreased expression:liver (human)
associated with liver cirrhosis;protein:increased expression:liver (human)		 RGD PMID:24815833 PMID:17270214 PMID:24696415 RGD:26884345, RGD:26884348, RGD:26884352 NCBI chr16:26,175,395...26,190,589
Ensembl chr16:26,175,392...26,190,591 		JBrowse link
G Clec1b C-type lectin domain family 1, member b ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 6:129,374,260...129,382,376
Ensembl chr 6:129,374,260...129,386,298 		JBrowse link
G Clec4g C-type lectin domain family 4, member g ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:3,757,066...3,770,695
Ensembl chr 8:3,757,064...3,770,651 		JBrowse link
G Clptm1l CLPTM1-like susceptibility
disease_progression		 ISO DNA:SNPs::rs401681(human)
DNA:SNP: :rs401681(human)		 RGD PMID:25339005 PMID:29042796 RGD:150530496, RGD:150537100 NCBI chr13:73,752,121...73,768,758
Ensembl chr13:73,752,125...73,768,724 		JBrowse link
G Cltrn collectrin, amino acid transport regulator ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr  X:162,873,183...162,901,855
Ensembl chr  X:162,871,826...162,901,856 		JBrowse link
G Cndp1 carnosine dipeptidase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr18:84,628,509...84,668,359
Ensembl chr18:84,628,634...84,668,220 		JBrowse link
G Cnot9 CCR4-NOT transcription complex, subunit 9 ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar PMID:26619011 NCBI chr 1:74,545,192...74,570,001
Ensembl chr 1:74,545,217...74,570,001 		JBrowse link
G Cntnap4 contactin associated protein-like 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:113,296,523...113,609,339
Ensembl chr 8:113,296,675...113,609,349 		JBrowse link
G Col15a1 collagen, type XV, alpha 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:47,207,744...47,313,165
Ensembl chr 4:47,208,161...47,313,167 		JBrowse link
G Col18a1 collagen, type XVIII, alpha 1 severity ISO Protein:increased expression RGD PMID:15739185 RGD:1600906 NCBI chr10:76,888,013...77,002,351
Ensembl chr10:76,888,012...77,002,382 		JBrowse link
G Colec10 collectin sub-family member 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr15:54,274,170...54,329,755
Ensembl chr15:54,274,170...54,329,754 		JBrowse link
G Comt catechol-O-methyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:15341023 NCBI chr16:18,225,632...18,247,006
Ensembl chr16:18,225,636...18,245,602 		JBrowse link
G Cops5 COP9 (constitutive photomorphogenic), subunit 5 (Arabidopsis) severity ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:liver (human)		 CTD
RGD		 PMID:20698225 PMID:26606000 RGD:11354707 NCBI chr 1:10,094,825...10,108,384
Ensembl chr 1:10,094,826...10,108,393 		JBrowse link
G Cox7b2 cytochrome c oxidase subunit 7B2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 5:71,600,166...71,705,548
Ensembl chr 5:71,600,167...71,705,548 		JBrowse link
G Cp ceruloplasmin ISO CTD Direct Evidence: marker/mechanism CTD PMID:19229483 NCBI chr 3:20,011,097...20,063,914
Ensembl chr 3:20,011,218...20,063,309 		JBrowse link
G Cpeb3 cytoplasmic polyadenylation element binding protein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr19:36,996,742...37,185,018
Ensembl chr19:36,998,691...37,186,000 		JBrowse link
G Cps1 carbamoyl-phosphate synthetase 1 disease_progression ISO associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr 1:67,151,294...67,270,426
Ensembl chr 1:67,162,185...67,270,418 		JBrowse link
G Crebbp CREB binding protein ISO ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: LIVER CELL CARCINOMA ClinVar PMID:21390126 PMID:21680795 PMID:21796119 PMID:22832583 PMID:23334668 More... NCBI chr16:3,899,198...4,031,864
Ensembl chr16:3,899,192...4,031,861 		JBrowse link
G Crhbp corticotropin releasing hormone binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr13:95,567,884...95,581,339
Ensembl chr13:95,567,879...95,581,432 		JBrowse link
G Crp C-reactive protein, pentraxin-related ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 NCBI chr 1:172,525,623...172,527,533
Ensembl chr 1:172,525,622...172,660,598 		JBrowse link
G Csf1r colony stimulating factor 1 receptor severity
exacerbates		 ISO DNA:hypomethylation:promoter (human)
protein:increased expression: liver (human)
protein:increased expression:liver (human)		 RGD PMID:32724427 PMID:32760707 PMID:11412385 PMID:14969845 RGD:150524282, RGD:150524286, RGD:150524301, RGD:150524302 NCBI chr18:61,238,644...61,264,211
Ensembl chr18:61,233,670...61,265,221 		JBrowse link
G Csf2 colony stimulating factor 2 (granulocyte-macrophage) treatment IMP RGD PMID:12731087 RGD:10450243 NCBI chr11:54,138,096...54,140,725
Ensembl chr11:54,138,097...54,140,493 		JBrowse link
G Csk c-src tyrosine kinase ISO protein:decreased expression:liver RGD PMID:9918913 RGD:5134372 NCBI chr 9:57,533,929...57,560,758
Ensembl chr 9:57,533,929...57,560,914 		JBrowse link
G Csmd1 CUB and Sushi multiple domains 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:15,942,538...17,586,908
Ensembl chr 8:15,942,537...17,585,602 		JBrowse link
G Cspg4 chondroitin sulfate proteoglycan 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:56,772,388...56,807,154
Ensembl chr 9:56,772,317...56,807,154 		JBrowse link
G Csrnp1 cysteine-serine-rich nuclear protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:119,800,229...119,813,808
Ensembl chr 9:119,800,229...119,813,724 		JBrowse link
G Ctla4 cytotoxic T-lymphocyte-associated protein 4 susceptibility ISO protein:increased expression:CD4+ and CD8+ T cells:
DNA:SNPs: :rs231775,rs231725(human)		 RGD PMID:28648905 PMID:23432218 RGD:14398741, RGD:14398742 NCBI chr 1:60,948,184...60,954,991
Ensembl chr 1:60,926,159...60,954,991 		JBrowse link
G Ctnnb1 catenin beta 1 susceptibility
severity
exacerbates		 ISO DNA:mutation:exon 3
CTD Direct Evidence: marker/mechanism
associated with Hepatitis B, Chronic,DNA:SNP, haplotype: :rs3864004 (human)
associated with hepatitis B;DNA:SNPs: :rs3864004,rs11564475(human)
protein:increased expression:liver:
DNA:Mutations:exon:
DNA:missense mutations:exon 3:multiple (human)
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma | ClinVar Annotator: match by term: LIVER CELL CARCINOMA		 OMIM
CTD
ClinVar
RGD		 PMID:9065402 PMID:9065403 PMID:9294210 PMID:9500465 PMID:9927029 More... RGD:734850, RGD:14402039, RGD:14402040, RGD:14402052, RGD:14402052, RGD:150429592 NCBI chr 9:120,762,466...120,789,573
Ensembl chr 9:120,758,282...120,789,573 		JBrowse link
G Ctsb cathepsin B ISO RGD PMID:15641152 RGD:2315605 NCBI chr14:63,359,911...63,383,372
Ensembl chr14:63,359,911...63,383,372 		JBrowse link
G Ctsd cathepsin D ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 7:141,929,647...141,941,564
Ensembl chr 7:141,929,648...141,941,775 		JBrowse link
G Ctsl cathepsin L ISO RGD PMID:15641152 RGD:2315605 NCBI chr13:64,509,704...64,518,586
Ensembl chr13:64,507,151...64,518,704 		JBrowse link
G Cux1 cut-like homeobox 1 ISO mRNA:increased expression:liver (human) RGD PMID:30561038 RGD:152985541 NCBI chr 5:136,276,989...136,596,429
Ensembl chr 5:136,276,989...136,596,344 		JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 disease_progression
treatment		 ISO
IDA		 RGD PMID:28592115 PMID:28638480 PMID:27245433 RGD:27095889, RGD:27095898, RGD:27095899 NCBI chr 5:92,494,497...92,496,748
Ensembl chr 5:92,494,497...92,496,748 		JBrowse link
G Cxcl11 chemokine (C-X-C motif) ligand 11 IEP mRNA:increased expression:liver (mouse) RGD PMID:26569409 RGD:11344640 NCBI chr 5:92,507,403...92,511,155
Ensembl chr 5:92,507,403...92,513,344 		JBrowse link
G Cxcl12 C-X-C motif chemokine ligand 12 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 PMID:28284560 NCBI chr 6:117,145,496...117,158,329
Ensembl chr 6:117,145,496...117,158,328 		JBrowse link
G Cxcl14 C-X-C motif chemokine ligand 14 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr13:56,436,456...56,444,624
Ensembl chr13:56,436,456...56,444,364 		JBrowse link
G Cxcl15 C-X-C motif chemokine ligand 15 disease_progression
susceptibility		 ISO protein:increased expression:liver (human)
mRNA:increased expression:liver (human)
DNA:SNPs, haplotype:multiple
CTD Direct Evidence: marker/mechanism|therapeutic		 CTD
RGD		 PMID:12432545 PMID:35776891 PMID:26078356 PMID:30523154 PMID:24381110 RGD:11526468, RGD:26884364, RGD:26884366 NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926 		JBrowse link
G Cxcr4 C-X-C motif chemokine receptor 4 treatment
severity		 ISO human cells in mouse model
protein:increased expression:liver (human)		 RGD PMID:30034941 PMID:33574707 RGD:151665331, RGD:151665327 NCBI chr 1:128,515,936...128,520,036
Ensembl chr 1:128,515,936...128,520,030 		JBrowse link
G Cyld CYLD lysine 63 deubiquitinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21109933 NCBI chr 8:89,423,506...89,478,574
Ensembl chr 8:89,423,675...89,478,573 		JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15341023 NCBI chr19:46,655,604...46,661,439
Ensembl chr19:46,655,604...46,661,611 		JBrowse link
G Cyp1a1 cytochrome P450, family 1, subfamily a, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15341023 NCBI chr 9:57,595,211...57,611,107
Ensembl chr 9:57,595,211...57,611,107 		JBrowse link
G Cyp1a2 cytochrome P450, family 1, subfamily a, polypeptide 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:57,584,220...57,590,938
Ensembl chr 9:57,584,220...57,590,986 		JBrowse link
G Cyp26b1 cytochrome P450, 26, retinoic acid B1 disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr 6:84,548,396...84,570,890
Ensembl chr 6:84,548,396...84,570,890 		JBrowse link
G Cyp2b10 cytochrome P450, family 2, subfamily b, polypeptide 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:25,597,083...25,626,049
Ensembl chr 7:25,597,045...25,626,049 		JBrowse link
G Cyp2c29 cytochrome P450, family 2, subfamily c, polypeptide 29 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr19:39,275,541...39,319,157
Ensembl chr19:39,257,849...39,319,157 		JBrowse link
G Cyp2c38 cytochrome P450, family 2, subfamily c, polypeptide 38 susceptibility ISO associated with hepatitis C; DNA:polymorphisms: : RGD PMID:11021356 RGD:124713413 NCBI chr19:39,379,109...39,451,519
Ensembl chr19:39,378,000...39,451,519 		JBrowse link
G Cyp2e1 cytochrome P450, family 2, subfamily e, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism
associated with alcohol dependence
DNA, mRNA:SNP, Decreased expression:liver: rs2031920 (human)		 CTD
RGD		 PMID:15162526 PMID:20364586 PMID:29765251 RGD:14700882, RGD:14700899 NCBI chr 7:140,343,732...140,354,903
Ensembl chr 7:140,343,652...140,354,900 		JBrowse link
G Cyp39a1 cytochrome P450, family 39, subfamily a, polypeptide 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr17:43,978,263...44,062,322
Ensembl chr17:43,978,316...44,062,322 		JBrowse link
G Dab2ip disabled 2 interacting protein severity ISO mRNA:decreased expression:liver (human)
protein:decreased expression:liver (human)		 RGD PMID:31176165 PMID:22168621 RGD:151665110, RGD:151665148 NCBI chr 2:35,448,285...35,621,006
Ensembl chr 2:35,448,278...35,621,006 		JBrowse link
G Dbh dopamine beta hydroxylase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:27,055,519...27,073,216
Ensembl chr 2:27,055,245...27,073,212 		JBrowse link
G Dcn decorin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:97,315,362...97,354,025
Ensembl chr10:97,315,471...97,354,005 		JBrowse link
G Ddr1 discoidin domain receptor family, member 1 severity IMP
ISO		 mRNA:increased expression:liver (human) RGD PMID:33173221 PMID:33173221 RGD:151347691, RGD:151347691 NCBI chr17:35,992,459...36,015,633
Ensembl chr17:35,992,459...36,015,513 		JBrowse link
G Ddr2 discoidin domain receptor family, member 2 treatment
disease_progression		 ISO RGD PMID:33969575 PMID:26362312 RGD:150429748, RGD:11086753 NCBI chr 1:169,799,874...169,938,525
Ensembl chr 1:169,799,876...169,938,331 		JBrowse link
G Ddx3x DEAD box helicase 3, X-linked exacerbates
sexual_dimorphism 		IMP
ISO		 associated with hepatitis B; mRNA,protein:decreased expression:liver (human) RGD PMID:30297359 PMID:16301996 RGD:151356499, RGD:151356660 NCBI chr  X:13,147,261...13,160,222
Ensembl chr  X:13,147,209...13,160,291 		JBrowse link
G Depdc1a DEP domain containing 1a ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:159,201,042...159,235,690
Ensembl chr 3:159,201,070...159,235,592 		JBrowse link
G Depdc1b DEP domain containing 1B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr13:108,452,592...108,526,100
Ensembl chr13:108,452,866...108,544,316 		JBrowse link
G Depdc5 DEP domain containing 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21725309 NCBI chr 5:33,020,996...33,151,581
Ensembl chr 5:33,021,045...33,151,580 		JBrowse link
G Dhfr dihydrofolate reductase ISO ClinVar Annotator: match by term: Hepatocellular cancer ClinVar PMID:28492532 NCBI chr13:92,491,291...92,525,561
Ensembl chr13:92,491,234...92,525,561 		JBrowse link
G Dicer1 dicer 1, ribonuclease type III susceptibility ISO associated with hepatitis B; DNA:SNP: :rs1057035 T>C (human) RGD PMID:23868705 RGD:149735346 NCBI chr12:104,654,001...104,718,331
Ensembl chr12:104,654,001...104,718,211 		JBrowse link
G Dipk2b divergent protein kinase domain 2B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr  X:18,280,406...18,327,657
Ensembl chr  X:18,281,120...18,327,636 		JBrowse link
G Dlgap5 DLG associated protein 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr14:47,625,238...47,655,657
Ensembl chr14:47,625,236...47,655,864 		JBrowse link
G Dlk1 delta like non-canonical Notch ligand 1 IEP mRNA:increased expression:liver (mouse) RGD PMID:26569409 RGD:11344640 NCBI chr12:109,418,411...109,429,262
Ensembl chr12:109,418,749...109,429,262 		JBrowse link
G Dmgdh dimethylglycine dehydrogenase precursor disease_progression ISO associated with tumor vascularization; mRNA,protein:decreased expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr13:93,810,944...93,889,331
Ensembl chr13:93,810,941...93,889,341 		JBrowse link
G Dnajc6 DnaJ heat shock protein family (Hsp40) member C6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:101,353,751...101,499,996
Ensembl chr 4:101,353,828...101,499,996 		JBrowse link
G Dnase1l3 deoxyribonuclease 1-like 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr14:14,475,014...14,504,586
Ensembl chr14:14,475,200...14,505,240 		JBrowse link
G Dnmt1 DNA methyltransferase 1 ISO mRNA, protein:increased expression:liver RGD PMID:11844796 RGD:2289670 NCBI chr 9:20,818,501...20,871,084
Ensembl chr 9:20,818,505...20,871,184 		JBrowse link
G Dnmt3a DNA methyltransferase 3A ISO protein:increased expression:liver:
mRNA, protein:increased expression:liver		 RGD PMID:15885882 PMID:11844796 RGD:9588598, RGD:2289670 NCBI chr12:3,851,559...3,964,442
Ensembl chr12:3,856,007...3,964,443 		JBrowse link
G Dnmt3b DNA methyltransferase 3B ISO mRNA:increased expression:liver:
mRNA, protein:increased expression:liver		 RGD PMID:15885882 PMID:11844796 RGD:9588598, RGD:2289670 NCBI chr 2:153,491,332...153,529,650
Ensembl chr 2:153,491,370...153,529,650 		JBrowse link
G Dpyd dihydropyrimidine dehydrogenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:18019677 NCBI chr 3:118,355,758...119,226,573
Ensembl chr 3:118,355,778...119,226,573 		JBrowse link
G Dsn1 DSN1 homolog, MIS12 kinetochore complex component disease_progression ISO RGD PMID:30136646 RGD:27372884 NCBI chr 2:156,836,982...156,848,995
Ensembl chr 2:156,837,185...156,849,074 		JBrowse link
G Dtl denticleless E3 ubiquitin protein ligase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:191,269,468...191,307,656
Ensembl chr 1:191,269,468...191,307,656 		JBrowse link
G Dynlrb1 dynein light chain roadblock-type 1 ISO RGD PMID:11750132 RGD:13208527 NCBI chr 2:155,078,453...155,092,197
Ensembl chr 2:155,078,453...155,092,197 		JBrowse link
G Dynlrb2 dynein light chain roadblock-type 2 ISO RGD PMID:11750132 RGD:13208527 NCBI chr 8:117,231,754...117,242,654
Ensembl chr 8:117,231,713...117,242,654 		JBrowse link
G E2f1 E2F transcription factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12029619 PMID:15565109 PMID:28284560 NCBI chr 2:154,401,320...154,411,812
Ensembl chr 2:154,401,327...154,411,812 		JBrowse link
G E2f8 E2F transcription factor 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:48,516,177...48,531,821
Ensembl chr 7:48,516,177...48,531,344 		JBrowse link
G Eaf2 ELL associated factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20564326 NCBI chr16:36,613,246...36,695,275
Ensembl chr16:36,613,246...36,695,365 		JBrowse link
G Ecm1 extracellular matrix protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:95,641,459...95,646,880
Ensembl chr 3:95,641,459...95,646,881 		JBrowse link
G Ect2 ect2 oncogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:27,151,371...27,207,971
Ensembl chr 3:27,151,371...27,208,027 		JBrowse link
G Eef2 eukaryotic translation elongation factor 2 exacerbates ISO protein:increased expression, increased phosphorylation:liver (human) RGD PMID:28060762 RGD:153298915 NCBI chr10:81,012,465...81,018,343
Ensembl chr10:81,012,465...81,018,332 		JBrowse link
G Efemp1 epidermal growth factor-containing fibulin-like extracellular matrix protein 1 disease_progression ISO protein:decreased expression:liver: RGD PMID:23936443 RGD:10401793 NCBI chr11:28,803,154...28,876,743
Ensembl chr11:28,803,204...28,876,743 		JBrowse link
G Eftud2 elongation factor Tu GTP binding domain containing 2 severity
ameliorates		 ISO RGD PMID:34282556 PMID:34282556 RGD:155791664, RGD:155791664 NCBI chr11:102,729,298...102,771,999
Ensembl chr11:102,729,299...102,771,811 		JBrowse link
G Egf epidermal growth factor susceptibility ISO CTD Direct Evidence: marker/mechanism
associated with liver cirrhosis;DNA:SNP:5'UTR: (rs4444903) (human)
associated with hepatitis B;DNA:SNP:exon: (rs11569017) (human)		 CTD
RGD		 PMID:9029167 PMID:18167406 PMID:23790025 RGD:14695013, RGD:14695014 NCBI chr 3:129,471,223...129,548,971
Ensembl chr 3:129,471,214...129,548,965 		JBrowse link
G Egfr epidermal growth factor receptor disease_progression ISO CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:9029167 PMID:11355950 RGD:126781769 NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158 		JBrowse link
G Egr1 early growth response 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr18:34,994,260...34,998,009
Ensembl chr18:34,992,876...34,998,037 		JBrowse link
G Egr2 early growth response 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:67,370,334...67,383,354
Ensembl chr10:67,371,305...67,378,018 		JBrowse link
G Ehd3 EH-domain containing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr17:74,111,836...74,139,088
Ensembl chr17:74,111,129...74,139,089 		JBrowse link
G Eif3h eukaryotic translation initiation factor 3, subunit H ISO CTD Direct Evidence: marker/mechanism CTD PMID:14578863 NCBI chr15:51,649,956...51,728,901
Ensembl chr15:51,649,954...51,728,919 		JBrowse link
G Enah ENAH actin regulator disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:35030977 RGD:155791678 NCBI chr 1:181,723,949...181,848,132
Ensembl chr 1:181,723,949...181,847,555 		JBrowse link
G Eng endoglin ISO protein:increased expression:liver (rat) RGD PMID:20368095 RGD:7257538 NCBI chr 2:32,536,607...32,572,681
Ensembl chr 2:32,536,607...32,572,681 		JBrowse link
G Eno1 enolase 1, alpha non-neuron ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 4:150,321,165...150,333,336
Ensembl chr 4:150,321,178...150,333,336 		JBrowse link
G Ep300 E1A binding protein p300 ISO protein:increased expression:liver (rat) RGD PMID:17083329 RGD:2312274 NCBI chr15:81,470,329...81,536,273
Ensembl chr15:81,469,552...81,536,278 		JBrowse link
G Epas1 endothelial PAS domain protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26735578 NCBI chr17:87,061,292...87,140,838
Ensembl chr17:87,061,128...87,140,838 		JBrowse link
G Epcam epithelial cell adhesion molecule severity ISO protein:increased expression:liver RGD PMID:24616575 RGD:14695007 NCBI chr17:87,943,407...87,958,555
Ensembl chr17:87,943,407...87,958,557 		JBrowse link
G Ephb1 Eph receptor B1 IEP protein:increased phosphorylation:liver (mouse) RGD PMID:28100771 RGD:127285675 NCBI chr 9:101,799,327...102,231,892
Ensembl chr 9:101,799,327...102,231,892 		JBrowse link
G Ephx1 epoxide hydrolase 1, microsomal ISO CTD Direct Evidence: marker/mechanism CTD PMID:7892276 NCBI chr 1:180,817,121...180,845,134
Ensembl chr 1:180,803,775...180,848,469 		JBrowse link
G Epo erythropoietin disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr 5:137,481,282...137,484,078
Ensembl chr 5:137,481,282...137,531,504 		JBrowse link
G Eps8l3 EPS8-like 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:107,781,177...107,800,216
Ensembl chr 3:107,784,545...107,800,216 		JBrowse link
G Erbb3 erb-b2 receptor tyrosine kinase 3 disease_progression ISO RGD PMID:11355950 RGD:126781769 NCBI chr10:128,403,392...128,425,504
Ensembl chr10:128,403,392...128,425,521 		JBrowse link
G Erbb4 erb-b2 receptor tyrosine kinase 4 ISO DNA:insertion/deletion:3'UTR:rs6147150 (human) RGD PMID:22294845 RGD:126781763 NCBI chr 1:68,071,063...69,147,756
Ensembl chr 1:68,071,345...69,147,218 		JBrowse link
G Ercc1 excision repair cross-complementing rodent repair deficiency, complementation group 1 ISO mRNA, protein:increased expression:liver (human) RGD PMID:15922480 RGD:155598683 NCBI chr 7:19,079,016...19,090,449
Ensembl chr 7:19,078,703...19,090,449 		JBrowse link
G Ercc2 excision repair cross-complementing rodent repair deficiency, complementation group 2 susceptibility
disease_progression		 ISO DNA:SNPs:exon 23: p.K751Q (human)
DNA:SNPs:exon 23: p.K751Q (human)
DNA:SNPs:exon 23: p.K751Q (rs13181) (human)
DNA:SNP:cd: 312A>G (human)		 RGD PMID:19919686 PMID:25531380 PMID:28598207 PMID:28927037 RGD:25671459, RGD:25671460, RGD:25671461, RGD:150530503 NCBI chr 7:19,115,942...19,129,619
Ensembl chr 7:19,115,935...19,129,619 		JBrowse link
G Ereg epiregulin ISO CTD Direct Evidence: marker/mechanism CTD PMID:35776891 NCBI chr 5:91,222,476...91,241,508
Ensembl chr 5:91,222,481...91,241,505 		JBrowse link
G Ern1 endoplasmic reticulum to nucleus signalling 1 ISO DNA:hypomethylation: CpG islands: RGD PMID:20165882 RGD:14694974 NCBI chr11:106,285,474...106,378,701
Ensembl chr11:106,285,476...106,378,678 		JBrowse link
G Erp29 endoplasmic reticulum protein 29 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 5:121,582,816...121,590,537
Ensembl chr 5:121,566,653...121,590,569 		JBrowse link
G Esm1 endothelial cell-specific molecule 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr13:113,346,193...113,354,638
Ensembl chr13:113,346,193...113,354,632 		JBrowse link
G Esr1 estrogen receptor 1 (alpha) ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 PMID:28284560 NCBI chr10:4,561,989...4,955,633
Ensembl chr10:4,561,593...4,955,614 		JBrowse link
G Etfa electron transferring flavoprotein, alpha polypeptide ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 9:55,361,720...55,419,528
Ensembl chr 9:55,361,792...55,419,527 		JBrowse link
G Exo1 exonuclease 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:175,708,334...175,738,962
Ensembl chr 1:175,708,147...175,741,055 		JBrowse link
G Ezh2 enhancer of zeste 2 polycomb repressive complex 2 subunit susceptibility ISO mRNA:increased expression:liver (human)
DNA:SNPs: :multiple
CTD Direct Evidence: marker/mechanism		 CTD
RGD		 PMID:28284560 PMID:34545456 PMID:24211739 PMID:26517514 PMID:24040354 More... RGD:10755339, RGD:11537550, RGD:126779595, RGD:126779608 NCBI chr 6:47,507,208...47,613,843
Ensembl chr 6:47,507,073...47,572,275 		JBrowse link
G F2 coagulation factor II severity ISO CTD Direct Evidence: marker/mechanism
associated with liver cirrhosis;protein:altered expression, altered processing:liver (human)		 CTD
RGD		 PMID:2821104 PMID:7620113 RGD:14975114 NCBI chr 2:91,442,742...91,466,799
Ensembl chr 2:91,455,665...91,466,759 		JBrowse link
G Fabp5 fatty acid binding protein 5, epidermal ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 3:10,077,645...10,081,670
Ensembl chr 3:10,077,608...10,081,667 		JBrowse link
G Fam180a family with sequence similarity 180, member A ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 6:35,289,678...35,303,076
Ensembl chr 6:35,289,603...35,303,076 		JBrowse link
G Fam83d family with sequence similarity 83, member D ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:158,610,011...158,628,557
Ensembl chr 2:158,610,013...158,628,557 		JBrowse link
G Fancd2 Fanconi anemia, complementation group D2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 6:113,508,622...113,573,981
Ensembl chr 6:113,508,643...113,573,978 		JBrowse link
G Fanci Fanconi anemia, complementation group I ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:79,042,056...79,100,013
Ensembl chr 7:79,041,677...79,100,012 		JBrowse link
G Fas Fas cell surface death receptor treatment ISO
IMP		 protein:increased expression:liver: RGD PMID:29634416 PMID:11274632 PMID:30737368 RGD:13792608, RGD:14700677, RGD:14700700 NCBI chr19:34,267,926...34,305,175
Ensembl chr19:34,268,066...34,305,172 		JBrowse link
G Fasl Fas ligand ISO protein:increased expression:liver: RGD PMID:11274632 RGD:14700677 NCBI chr 1:161,608,260...161,616,064
Ensembl chr 1:161,608,258...161,616,064 		JBrowse link
G Fasn fatty acid synthase ISO CTD Direct Evidence: marker/mechanism CTD PMID:14563831 PMID:15543204 PMID:21147110 NCBI chr11:120,696,784...120,715,992
Ensembl chr11:120,696,672...120,715,373 		JBrowse link
G Fat1 FAT atypical cadherin 1 disease_progression ISO mRNA,protein:increased expression:liver (human) RGD PMID:24590895 RGD:151347630 NCBI chr 8:45,386,137...45,505,294
Ensembl chr 8:45,388,484...45,505,294 		JBrowse link
G Fate1 fetal and adult testis expressed 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15580283 NCBI chr  X:71,016,592...71,032,652
Ensembl chr  X:71,016,592...71,032,652 		JBrowse link
G Fbp1 fructose bisphosphatase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22039417 NCBI chr13:63,012,567...63,036,112
Ensembl chr13:63,012,567...63,036,096 		JBrowse link
G Fbxl18 F-box and leucine-rich repeat protein 18 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 5:142,852,701...142,882,696
Ensembl chr 5:142,852,701...142,881,176 		JBrowse link
G Fbxo11 F-box protein 11 exacerbates
ameliorates		 ISO mRNA:increased expression:liver (human) RGD PMID:32657545 PMID:29518611 RGD:152025263, RGD:152025259 NCBI chr17:88,298,287...88,373,473
Ensembl chr17:88,298,287...88,372,719 		JBrowse link
G Fcna ficolin A ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:25,514,677...25,525,448
Ensembl chr 2:25,514,678...25,518,042 		JBrowse link
G Fdft1 farnesyl diphosphate farnesyl transferase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147110 NCBI chr14:63,382,599...63,419,136
Ensembl chr14:63,382,599...63,417,027 		JBrowse link
G Fes feline sarcoma oncogene exacerbates ISO DNA:hypermethylation:promoter (human) RGD PMID:31038805 RGD:153323297 NCBI chr 7:80,027,506...80,037,702
Ensembl chr 7:80,027,504...80,037,694 		JBrowse link
G Fgf15 fibroblast growth factor 15 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25822088 NCBI chr 7:144,450,269...144,454,690
Ensembl chr 7:144,450,268...144,454,690 		JBrowse link
G Fgf3 fibroblast growth factor 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25822088 NCBI chr 7:144,392,349...144,397,085
Ensembl chr 7:144,391,820...144,398,173 		JBrowse link
G Fgf4 fibroblast growth factor 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25822088 NCBI chr 7:144,415,123...144,418,982
Ensembl chr 7:144,401,104...144,418,980 		JBrowse link
G Fgfr1 fibroblast growth factor receptor 1 treatment ISO ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma
CTD Direct Evidence: marker/mechanism		 ClinVar
CTD
RGD		 PMID:25705862 PMID:26619011 PMID:26942290 PMID:33448156 PMID:36029209 More... RGD:25330358, RGD:25440476, RGD:25440478 NCBI chr 8:26,008,808...26,067,819
Ensembl chr 8:26,003,670...26,065,734 		JBrowse link
G Fgfr2 fibroblast growth factor receptor 2 severity ISO associated with hepatitis B;DNA:SNPs: promoter, intron:rs308379, rs1219648 (human) RGD PMID:30952770 RGD:38501096 NCBI chr 7:129,764,181...129,868,538
Ensembl chr 7:129,764,181...132,725,079 		JBrowse link
G Fgfr4 fibroblast growth factor receptor 4 treatment ISO RGD PMID:32677805 RGD:150520166 NCBI chr13:55,300,631...55,316,572
Ensembl chr13:55,300,453...55,316,572 		JBrowse link
G Fh1 fumarate hydratase 1 ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar PMID:10896297 PMID:15221078 PMID:16876016 PMID:17182618 PMID:18313410 More... NCBI chr 1:175,428,944...175,453,201
Ensembl chr 1:175,427,940...175,453,201 		JBrowse link
G Fhit fragile histidine triad gene ISO RGD PMID:12112319 RGD:632723 NCBI chr14:11,307,718...12,919,681
Ensembl chr14:11,307,738...12,919,681 		JBrowse link
G Flt3 FMS-like tyrosine kinase 3 ameliorates ISO human cells in mouse model RGD PMID:27511526 RGD:149735514 NCBI chr 5:147,267,551...147,337,299
Ensembl chr 5:147,267,551...147,337,299 		JBrowse link
G Flvcr1 feline leukemia virus subgroup C cellular receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:190,738,029...190,758,387
Ensembl chr 1:190,738,044...190,758,355 		JBrowse link
G Fos FBJ osteosarcoma oncogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:9029167 PMID:28284560 NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047 		JBrowse link
G Fosb FBJ osteosarcoma oncogene B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:19,036,621...19,043,970
Ensembl chr 7:19,036,621...19,043,976 		JBrowse link
G Fosl2 fos-like antigen 2 ISO mRNA:increased expression:liver (human) RGD PMID:30086463 PMID:32048611 RGD:153344517, RGD:153344521 NCBI chr 5:32,292,599...32,315,184
Ensembl chr 5:32,293,145...32,315,186 		JBrowse link
G Foxa1 forkhead box A1 susceptibility
disease_progression
sexual_dimorphism 		ISO DNA:VNTR, SNPs, haplotypes:multiple:
protein:decreased expression:liver		 RGD PMID:29208003 PMID:31400761 PMID:25965836 RGD:151665820, RGD:151665752, RGD:11054501 NCBI chr12:57,585,750...57,594,815
Ensembl chr12:57,587,414...57,593,702 		JBrowse link
G Foxm1 forkhead box M1 IAGP
ISO		 OMIM:114550
CTD Direct Evidence: marker/mechanism		 MouseDO
CTD		 PMID:15082532 PMID:17173139 PMID:28284560 NCBI chr 6:128,339,957...128,352,849
Ensembl chr 6:128,339,930...128,353,109 		JBrowse link
G Foxo1 forkhead box O1 ISO mRNA:decreased expression:liver RGD PMID:28972178 RGD:14401599 NCBI chr 3:52,175,758...52,257,530
Ensembl chr 3:52,175,757...52,260,642 		JBrowse link
G Foxp1 forkhead box P1 treatment ISO RGD PMID:25156538 RGD:9587823 NCBI chr 6:98,902,303...99,510,587
Ensembl chr 6:98,902,299...99,499,682 		JBrowse link
G Foxp3 forkhead box P3 ISO protein:increased expression:liver RGD PMID:21086571 RGD:38548919 NCBI chr  X:7,445,915...7,461,482
Ensembl chr  X:7,439,883...7,461,484 		JBrowse link
G Fst follistatin ISO CTD Direct Evidence: marker/mechanism CTD PMID:12203361 PMID:19363144 NCBI chr13:114,588,798...114,595,522
Ensembl chr13:114,588,826...114,595,487 		JBrowse link
G Fth1 ferritin heavy polypeptide 1 ISO mRNA:increased expression:liver (rat) RGD PMID:9054589 RGD:632698 NCBI chr19:9,957,964...9,962,475
Ensembl chr19:9,957,962...9,962,462 		JBrowse link
G Fubp1 far upstream element (FUSE) binding protein 1 exacerbates
ameliorates		 ISO mRNA:increased expression:liver (human)
human cell line in a mouse model
associated with Chronic Hepatitis C;mRNA:increased expression:liver (human)		 RGD PMID:31587040 PMID:19637194 PMID:25995247 RGD:151361188, RGD:151361194, RGD:151361196 NCBI chr 3:151,916,059...151,942,467
Ensembl chr 3:151,916,059...151,942,463 		JBrowse link
G G6pc1 glucose-6-phosphatase catalytic subunit 1 treatment ISO associated with Glycogen Storage Disease IA, human gene in a mouse model RGD PMID:28096054 RGD:14695537 NCBI chr11:101,258,542...101,268,729
Ensembl chr11:101,258,387...101,268,729 		JBrowse link
G G6pdx glucose-6-phosphate dehydrogenase X-linked disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:25473368 PMID:35693827 RGD:10449118, RGD:153344586 NCBI chr  X:73,453,089...73,472,486
Ensembl chr  X:73,453,089...73,472,800 		JBrowse link
G Gabrd gamma-aminobutyric acid (GABA) A receptor, subunit delta ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:155,469,437...155,482,528
Ensembl chr 4:155,469,437...155,482,569 		JBrowse link
G Gapdh glyceraldehyde-3-phosphate dehydrogenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16767786 PMID:21472284 NCBI chr 6:125,138,812...125,143,450
Ensembl chr 6:125,138,678...125,143,430 		JBrowse link
G Gc vitamin D binding protein susceptibility ISO protein:increased expression:liver
associated with Hepatitis B, Chronic;DNA:SNP: :rs7041(human)		 RGD PMID:21683810 PMID:25541958 RGD:5509919, RGD:14402025 NCBI chr 5:89,565,370...89,605,757
Ensembl chr 5:89,565,381...89,605,757 		JBrowse link
G Gdf15 growth differentiation factor 15 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20512989 NCBI chr 8:71,082,043...71,085,106
Ensembl chr 8:71,082,043...71,085,106 		JBrowse link
G Gdf2 growth differentiation factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23936038 PMID:28284560 NCBI chr14:33,662,996...33,669,155
Ensembl chr14:33,662,996...33,669,155 		JBrowse link
G Ggt1 gamma-glutamyltransferase 1 disease_progression ISO HBV associated
RNA,protein:increased expression, activity:liver:		 RGD PMID:11940314 PMID:27793641 PMID:10572675 RGD:14701040, RGD:14701041, RGD:14701048 NCBI chr10:75,396,910...75,422,027
Ensembl chr10:75,397,438...75,422,034 		JBrowse link
G Ghr growth hormone receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr15:3,347,237...3,612,834
Ensembl chr15:3,347,242...3,612,974 		JBrowse link
G Gins1 GINS complex subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:150,751,482...150,773,200
Ensembl chr 2:150,747,320...150,773,200 		JBrowse link
G Gjb1 gap junction protein, beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17978847 NCBI chr  X:100,419,982...100,429,235
Ensembl chr  X:100,419,984...100,429,235 		JBrowse link
G Gjb2 gap junction protein, beta 2 ISO DNA, mRNA:promoter hypermethylation, decreased expression:liver RGD PMID:17295234 RGD:2289638 NCBI chr14:57,336,059...57,342,159
Ensembl chr14:57,336,057...57,342,159 		JBrowse link
G Gli1 GLI-Kruppel family member GLI1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26189965 NCBI chr10:127,165,751...127,177,448
Ensembl chr10:127,165,751...127,177,843 		JBrowse link
G Glul glutamate-ammonia ligase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 NCBI chr 1:153,775,692...153,785,469
Ensembl chr 1:153,775,690...153,785,469 		JBrowse link
G Gm266 predicted gene 266 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr12:111,451,043...111,452,257
Ensembl chr12:111,451,043...111,452,257 		JBrowse link
G Gmnn geminin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr13:24,935,828...24,954,222
Ensembl chr13:24,935,828...24,945,906 		JBrowse link
G Gmps guanine monophosphate synthetase ISO protein:increased activity:hepatoma (rat) RGD PMID:6861338 RGD:5135537 NCBI chr 3:63,871,054...63,928,975
Ensembl chr 3:63,883,527...63,930,000 		JBrowse link
G Gnao1 guanine nucleotide binding protein, alpha O ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:94,537,213...94,696,016
Ensembl chr 8:94,536,594...94,696,016 		JBrowse link
G Gnas GNAS complex locus ISO ClinVar Annotator: match by term: Hepatocellular cancer ClinVar PMID:1517386 PMID:1594625 PMID:1944469 PMID:2549426 PMID:3720010 More... NCBI chr 2:174,126,113...174,188,537
Ensembl chr 2:174,126,113...174,188,537 		JBrowse link
G Gnaz guanine nucleotide binding protein, alpha z subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:74,803,009...74,852,739
Ensembl chr10:74,803,009...74,852,739 		JBrowse link
G Gnmt glycine N-methyltransferase IAGP
ISO		 OMIM:114550
CTD Direct Evidence: marker/mechanism		 MouseDO
CTD		 PMID:19146867 PMID:31086990 NCBI chr17:47,036,590...47,040,091
Ensembl chr17:47,036,590...47,040,094 		JBrowse link
G Golm1 golgi membrane protein 1 severity ISO protein:increased expression:serum
mRNA, protein:increased expression:liver		 RGD PMID:21140449 PMID:21443671 RGD:401827118, RGD:401827119 NCBI chr13:59,782,810...59,823,598
Ensembl chr13:59,782,440...59,823,625 		JBrowse link
G Gpc1 glypican 1 disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr 1:92,759,367...92,787,933
Ensembl chr 1:92,759,367...92,788,501 		JBrowse link
G Gpc3 glypican 3 severity
treatment
disease_progression
exacerbates		 ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:liver
protein:increased expression:serum
mRNA:increased expression:Peripheral Blood (human)
mRNA,protein:increased expression:peripheral blood mononuclear cell,blood serum, liver (human)
protein:increased expression:blood serum (human)
protein:increased expression:liver (human)		 CTD
RGD		 PMID:16698587 PMID:27286460 PMID:28284560 PMID:19496787 PMID:25449037 More... RGD:243065134, RGD:14695019, RGD:14695020, RGD:14695020, RGD:243065125, RGD:243065131, RGD:243065135, RGD:243065139 NCBI chr  X:51,361,303...51,702,851
Ensembl chr  X:51,361,303...51,702,827 		JBrowse link
G Gpm6a glycoprotein m6a ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:55,232,469...55,513,913
Ensembl chr 8:55,407,878...55,513,906 		JBrowse link
G Gpr158 G protein-coupled receptor 158 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:21,372,378...21,835,355
Ensembl chr 2:21,372,353...21,835,358 		JBrowse link
G Gpr182 G protein-coupled receptor 182 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:127,585,471...127,587,667
Ensembl chr10:127,583,145...127,587,601 		JBrowse link
G Gpx1 glutathione peroxidase 1 severity
susceptibility
no_association		 ISO associated with hepatitis C;DNA:missense mutation:CDS:p.P198L (rs1050450) (human)
associated with alcoholic liver cirrhosis;DNA:missense mutation:CDS:p.P198L (human)		 RGD PMID:26990426 PMID:16510607 PMID:19929244 PMID:25894370 RGD:11533013, RGD:151708729, RGD:152995483, RGD:152998906 NCBI chr 9:108,216,279...108,217,541
Ensembl chr 9:108,216,102...108,217,542 		JBrowse link
G Gpx3 glutathione peroxidase 3 severity
disease_progression		 ISO mRNA,protein:decreased expression:liver, blood plasma (human)
DNA:hypermethylation		 RGD PMID:25333265 PMID:25445749 PMID:27570561 RGD:151665355, RGD:151665509, RGD:401827855 NCBI chr11:54,793,680...54,801,213
Ensembl chr11:54,793,279...54,801,203 		JBrowse link
G Grb7 growth factor receptor bound protein 7 exacerbates ISO protein:increased expression:liver (human) RGD PMID:17634422 RGD:151347655 NCBI chr11:98,337,660...98,346,199
Ensembl chr11:98,337,220...98,346,199 		JBrowse link
G Gstm1 glutathione S-transferase, mu 1 susceptibility
no_association		 ISO DNA:deletion:cds (human)
CTD Direct Evidence: marker/mechanism		 CTD
RGD		 PMID:7892276 PMID:11859714 PMID:20683151 PMID:20672314 RGD:7488953, RGD:14700951, RGD:14700979 NCBI chr 3:107,919,566...107,925,289
Ensembl chr 3:107,919,571...107,925,289 		JBrowse link
G Gstp1 glutathione S-transferase, pi 1 ISO CTD Direct Evidence: marker/mechanism
DNA:increased methylation:promoter		 CTD
RGD		 PMID:9029167 PMID:22536438 RGD:14401712 NCBI chr19:4,085,411...4,087,912
Ensembl chr19:4,085,407...4,087,985 		JBrowse link
G Gstt1 glutathione S-transferase, theta 1 susceptibility
no_association		 ISO DNA:deletion RGD PMID:23053942 PMID:20683151 PMID:20672314 RGD:14401714, RGD:14700951, RGD:14700979 NCBI chr10:75,619,647...75,634,418
Ensembl chr10:75,619,647...75,634,418 		JBrowse link
G Gtse1 G two S phase expressed protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr15:85,743,928...85,760,774
Ensembl chr15:85,743,946...85,760,774 		JBrowse link
G Gys2 glycogen synthase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 6:142,368,339...142,418,856
Ensembl chr 6:142,368,339...142,418,835 		JBrowse link
G H19 H19, imprinted maternally expressed transcript ISO mRNA:increased expression:liver RGD PMID:17393425 RGD:2306187 NCBI chr 7:142,129,267...142,131,883
Ensembl chr 7:142,129,262...142,131,917 		JBrowse link
G H2-Aa histocompatibility 2, class II antigen A, alpha susceptibility ISO associated with Hepatitis B, Chronic;DNA:SNP: :rs9272105(human)
associated with Hepatitis B, Chronic;DNA:SNPs, haplotype: : rs9275572, rs2596542(human)		 RGD PMID:30160782 PMID:24204805 RGD:14398839, RGD:14401561 NCBI chr17:34,501,718...34,506,797
Ensembl chr17:34,501,718...34,506,797 		JBrowse link
G H2-Ab1 histocompatibility 2, class II antigen A, beta 1 treatment ISO associated with hepatitis B
associated with hepatitis C;DNA:SNPs,haplotypes		 RGD PMID:27288300 PMID:28921602 RGD:14928325, RGD:14974233 NCBI chr17:34,482,201...34,488,392
Ensembl chr17:34,476,663...34,488,393 		JBrowse link
G H2-Pa histocompatibility 2, P region alpha locus ISO DNA:hypomethylation: CpG islands: RGD PMID:20165882 RGD:14694974 NCBI chr17:34,303,587...34,304,826
Ensembl chr17:34,303,575...34,304,797 		JBrowse link
G Hamp hepcidin antimicrobial peptide ISO
IEP
IDA		 CTD Direct Evidence: marker/mechanism
mRNA:decreased expression:liver (human)
DNA:hypermethylation,hypomethylation:promoter		 CTD
RGD		 PMID:28284560 PMID:29235098 PMID:29235098 RGD:15042879, RGD:15042879 NCBI chr 7:30,641,793...30,643,454
Ensembl chr 7:30,641,793...30,643,457 		JBrowse link
G Hao2 hydroxyacid oxidase 2, kidney ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:98,781,835...98,802,692
Ensembl chr 3:98,781,837...98,800,555 		JBrowse link
G Havcr1 hepatitis A virus cellular receptor 1 disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr11:46,630,644...46,670,405
Ensembl chr11:46,625,907...46,670,405 		JBrowse link
G Havcr2 hepatitis A virus cellular receptor 2 disease_progression ISO associated with hepatitis B;DNA:SNP: : ���1516 G>T (human) RGD PMID:27034168 RGD:40818257 NCBI chr11:46,345,758...46,372,082
Ensembl chr11:46,345,762...46,372,082 		JBrowse link
G Hdac2 histone deacetylase 2 disease_progression ISO mRNA:increased expression:liver: RGD PMID:24448241 RGD:9590206 NCBI chr10:36,850,293...36,877,885
Ensembl chr10:36,850,540...36,877,885 		JBrowse link
G Hdac4 histone deacetylase 4 ISO mRNA:increased expression:liver: RGD PMID:21837748 RGD:9681451 NCBI chr 1:91,856,501...92,123,424
Ensembl chr 1:91,856,501...92,123,421 		JBrowse link
G Hfe homeostatic iron regulator disease_progression ISO associated with Liver Cirrhosis;DNA:missense mutation:cds:p.C282Y (human) RGD PMID:20019189 PMID:29642405 RGD:2317357, RGD:14746967 NCBI chr13:23,886,017...23,894,837
Ensembl chr13:23,886,017...23,894,837 		JBrowse link
G Hgf hepatocyte growth factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:9932610 PMID:11896611 NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150 		JBrowse link
G Hgfac hepatocyte growth factor activator ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 NCBI chr 5:35,198,853...35,205,805
Ensembl chr 5:35,198,853...35,205,805 		JBrowse link
G Hhip Hedgehog-interacting protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:18559595 NCBI chr 8:80,692,480...80,784,637
Ensembl chr 8:80,692,480...80,784,635 		JBrowse link
G Hif1a hypoxia inducible factor 1, alpha subunit treatment
disease_progression		 ISO protein:increased expression:liver (human) RGD PMID:19335982 PMID:26078356 PMID:31321740 RGD:9068886, RGD:11526468, RGD:155882550 NCBI chr12:73,948,186...73,994,304
Ensembl chr12:73,948,149...73,994,304 		JBrowse link
G Hilpda hypoxia inducible lipid droplet associated disease_progression ISO mRNA, protein:increased expression:liver (human)
human cells in mouse model
mRNA:increased expression:liver (human)		 RGD PMID:31142329 PMID:31142329 PMID:30205391 PMID:35693827 RGD:153344574, RGD:153344574, RGD:153344577, RGD:153344586 NCBI chr 6:29,272,487...29,275,448
Ensembl chr 6:29,272,487...29,275,445 		JBrowse link
G Hjurp Holliday junction recognition protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:88,186,578...88,205,366
Ensembl chr 1:88,190,193...88,205,355 		JBrowse link
G Hmgb2 high mobility group box 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20851854 NCBI chr 8:57,964,877...57,969,033
Ensembl chr 8:57,964,941...57,969,033 		JBrowse link
G Hmgcr 3-hydroxy-3-methylglutaryl-Coenzyme A reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:9207284 PMID:21147110 NCBI chr13:96,785,470...96,807,444
Ensembl chr13:96,785,475...96,807,444 		JBrowse link
G Hmgcs2 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 disease_progression ISO RGD PMID:28867541 RGD:14975299 NCBI chr 3:98,187,747...98,218,054
Ensembl chr 3:98,187,751...98,218,054 		JBrowse link
G Hmmr hyaluronan mediated motility receptor (RHAMM) ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr11:40,592,215...40,624,290
Ensembl chr11:40,592,222...40,624,249 		JBrowse link
G Hnf1a HNF1 homeobox A treatment IMP human cell line in mouse model RGD PMID:29466992 RGD:14700664 NCBI chr 5:115,087,039...115,109,121
Ensembl chr 5:115,087,039...115,109,153 		JBrowse link
G Hnf4a hepatic nuclear factor 4, alpha ISO protein:decreased expression:liver: RGD PMID:20876809 PMID:20876809 RGD:12904747, RGD:12904747 NCBI chr 2:163,348,731...163,414,827
Ensembl chr 2:163,348,728...163,414,830 		JBrowse link
G Hnrnpa1 heterogeneous nuclear ribonucleoprotein A1 ISO protein:increased expression:liver (human) RGD PMID:23633480 RGD:9685423 NCBI chr15:103,148,840...103,155,119
Ensembl chr15:103,148,859...103,155,119 		JBrowse link
G Hnrnpa2b1 heterogeneous nuclear ribonucleoprotein A2/B1 ISO protein:increased expression:liver (human)
mRNA:increased expression:liver (rat)		 RGD PMID:20604928 PMID:23633480 RGD:9685422, RGD:9685423 NCBI chr 6:51,437,414...51,448,054
Ensembl chr 6:51,437,912...51,446,874 		JBrowse link
G Hnrnpab heterogeneous nuclear ribonucleoprotein A/B severity ISO mRNA:increased expression:liver (human) RGD PMID:24638979 RGD:10059322 NCBI chr11:51,490,927...51,497,708
Ensembl chr11:51,490,927...51,497,674 		JBrowse link
G Hnrnpd heterogeneous nuclear ribonucleoprotein D ISO protein:increased expression:liver (human)
protein:increased expression:liver (rat)		 RGD PMID:20102719 PMID:22318685 RGD:10042969, RGD:10042977 NCBI chr 5:100,103,794...100,126,926
Ensembl chr 5:100,103,794...100,126,797 		JBrowse link
G Hnrnph1 heterogeneous nuclear ribonucleoprotein H1 ISO protein:increased expression:liver (human) RGD PMID:23633480 RGD:9685423 NCBI chr11:50,266,084...50,277,355
Ensembl chr11:50,267,817...50,277,355 		JBrowse link
G Hnrnpl heterogeneous nuclear ribonucleoprotein L ISO associated with Hepatitis B RGD PMID:24125732 RGD:9999429 NCBI chr 7:28,507,971...28,521,693
Ensembl chr 7:28,507,966...28,521,691 		JBrowse link
G Hotair HOX transcript antisense RNA (non-protein coding) ISO CTD Direct Evidence: marker/mechanism CTD PMID:21327457 NCBI chr15:102,852,497...102,856,381
Ensembl chr15:102,852,494...102,856,165 		JBrowse link
G Hoxa10 homeobox A10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 6:52,208,177...52,217,658
Ensembl chr 6:52,208,177...52,217,834 		JBrowse link
G Hoxa13 homeobox A13 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 6:52,235,833...52,237,865
Ensembl chr 6:52,234,674...52,237,788 		JBrowse link
G Hoxd9 homeobox D9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:74,528,107...74,530,552
Ensembl chr 2:74,528,071...74,530,552 		JBrowse link
G Hp haptoglobin ISO protein:increased expression:saliva
protein:decreased expression:liver (human)		 RGD PMID:31041878 PMID:24259486 RGD:27095881, RGD:152995276 NCBI chr 8:110,301,760...110,305,804
Ensembl chr 8:110,301,760...110,305,804 		JBrowse link
G Hprt1 hypoxanthine phosphoribosyltransferase 1 ISO protein:increased activity:hepatoma (rat) RGD PMID:6327016 RGD:5135035 NCBI chr  X:52,076,955...52,110,537
Ensembl chr  X:52,077,014...52,110,536 		JBrowse link
G Hras Harvey rat sarcoma virus oncogene treatment ISO
IEP		 CTD Direct Evidence: marker/mechanism
protein:increased expression:liver (human)
human cells in a mouse model
human plasmid in a mouse model
mRNA:increased expression:liver (mouse)
ClinVar Annotator: match by term: Hepatocellular cancer
ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma		 CTD
ClinVar
RGD		 PMID:8200073 PMID:9311599 PMID:11150980 PMID:12835555 PMID:16155195 More... RGD:14688054, RGD:14688055, RGD:14694809, RGD:14694810 NCBI chr 7:140,770,839...140,773,938
Ensembl chr 7:140,769,018...140,773,918 		JBrowse link
G Hspa5 heat shock protein 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 PMID:29698666 NCBI chr 2:34,662,102...34,666,541
Ensembl chr 2:34,661,982...34,667,559 		JBrowse link
G Hspa9 heat shock protein 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr18:35,070,467...35,087,404
Ensembl chr18:35,070,467...35,087,410 		JBrowse link
G Hspb1 heat shock protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr 5:135,916,773...135,918,417
Ensembl chr 5:135,916,773...135,918,417 		JBrowse link
G Htatip2 HIV-1 Tat interactive protein 2 ISO CTD Direct Evidence: therapeutic CTD PMID:16799960 NCBI chr 7:49,408,761...49,423,748
Ensembl chr 7:49,408,863...49,423,723 		JBrowse link
G Htra1 HtrA serine peptidase 1 exacerbates
disease_progression		 ISO protein:decreased expression:liver (human)
mRNA:decreased expression:liver (human)		 RGD PMID:20943460 PMID:26403966 RGD:152985524, RGD:152985529 NCBI chr 7:130,537,933...130,587,388
Ensembl chr 7:130,537,841...130,587,390 		JBrowse link
G Icam1 intercellular adhesion molecule 1 severity ISO protein:increased expression:serum RGD PMID:26109813 RGD:11056752 NCBI chr 9:20,927,236...20,940,110
Ensembl chr 9:20,927,281...20,940,113 		JBrowse link
G Idh1 isocitrate dehydrogenase 1 (NADP+), soluble ISO CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Hepatocellular cancer		 CTD
ClinVar		 PMID:18772396 PMID:19657110 PMID:19798509 PMID:19818334 PMID:20946881 More... NCBI chr 1:65,197,775...65,225,638
Ensembl chr 1:65,197,775...65,225,659 		JBrowse link
G Idh2 isocitrate dehydrogenase 2 (NADP+), mitochondrial disease_progression ISO ClinVar Annotator: match by term: Hepatocellular cancer ClinVar
RGD		 PMID:20946881 PMID:21250968 PMID:21596855 PMID:21997850 PMID:22160010 More... RGD:14985249 NCBI chr 7:79,744,594...79,768,356
Ensembl chr 7:79,744,594...79,765,140 		JBrowse link
G Ier2 immediate early response 2 ISO mRNA, protein:decreased expression:liver (human) RGD PMID:32009420 RGD:153323326 NCBI chr 8:85,387,960...85,389,481
Ensembl chr 8:85,387,960...85,389,483 		JBrowse link
G Ifna1 interferon alpha 1 susceptibility ISO CTD Direct Evidence: therapeutic
associated with hepatitis B; DNA:SNP:: ( rs1831583) (human)		 CTD
RGD		 PMID:17088986 PMID:17971768 PMID:18665156 PMID:29080269 RGD:21406429 NCBI chr 4:88,768,324...88,768,893
Ensembl chr 4:88,768,324...88,768,893 		JBrowse link
G Ifna2 interferon alpha 2 susceptibility ISO associated with hepatitis B; DNA:SNP:enhancer: (rs649053) (human) RGD PMID:29080269 RGD:21406429 NCBI chr 4:88,601,444...88,602,016
Ensembl chr 4:88,601,118...88,602,149 		JBrowse link
G Ifng interferon gamma IEP mRNA:increased expression:liver (mouse) RGD PMID:26569409 RGD:11344640 NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797 		JBrowse link
G Igbp1 immunoglobulin (CD79A) binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21339737 NCBI chr  X:99,537,897...99,559,731
Ensembl chr  X:99,537,897...99,559,731 		JBrowse link
G Igf1 insulin-like growth factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:87,694,127...87,772,909
Ensembl chr10:87,694,127...87,772,904 		JBrowse link
G Igf1r insulin-like growth factor I receptor susceptibility ISO CTD Direct Evidence: marker/mechanism
DNA:SNPs, haplotype: :		 CTD
RGD		 PMID:17441810 PMID:23958494 PMID:24758241 RGD:14985227 NCBI chr 7:67,601,486...67,883,416
Ensembl chr 7:67,602,575...67,883,416 		JBrowse link
G Igf2 insulin-like growth factor 2 susceptibility ISO CTD Direct Evidence: marker/mechanism
associated with hepatitis B;DNA:SNPs:intron, 3'utr:+2482A>C, +820A>G (human)		 CTD
RGD		 PMID:12532445 PMID:16092956 PMID:17554210 PMID:16750516 RGD:2311523, RGD:14401723 NCBI chr 7:142,204,505...142,220,566
Ensembl chr 7:142,204,503...142,220,553 		JBrowse link
G Igf2bp1 insulin-like growth factor 2 mRNA binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr11:95,847,989...95,896,770
Ensembl chr11:95,847,989...95,896,766 		JBrowse link
G Igf2bp3 insulin-like growth factor 2 mRNA binding protein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 6:49,062,152...49,200,225
Ensembl chr 6:49,062,157...49,191,891 		JBrowse link
G Igf2r insulin-like growth factor 2 receptor disease_progression
no_association
treatment		 ISO DNA:mutation:G1449V (human)
CTD Direct Evidence: marker/mechanism
protein:increased expression:serum:
DNA:loss of heterozygosity:liver
DNA:loss of heterozygosity,mutations:liver:
associated with hepatitis B virus; mRNA:decreased expression:liver:
ClinVar Annotator: match by term: Hepatocellular carcinoma		 OMIM
CTD
ClinVar
RGD		 PMID:9722161 PMID:15057872 PMID:25741868 PMID:7493029 PMID:29940770 More... RGD:1624323, RGD:14985218, RGD:14985219, RGD:14985220, RGD:14985221, RGD:14985222, RGD:14985225 NCBI chr17:12,901,293...12,988,593
Ensembl chr17:12,901,293...12,988,551 		JBrowse link
G Igfals insulin-like growth factor binding protein, acid labile subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr17:25,096,818...25,100,985
Ensembl chr17:25,084,971...25,100,984 		JBrowse link
G Ikbkg inhibitor of kappaB kinase gamma treatment IMP
ISO		 protein:decreased expression:liver (human) RGD PMID:29551768 PMID:22176836 PMID:25173965 PMID:17292824 PMID:24971483 More... RGD:153297807, RGD:153297813, RGD:153305943, RGD:153305945, RGD:11079569, RGD:153305947 NCBI chr  X:73,436,883...73,498,013
Ensembl chr  X:73,436,896...73,497,460 		JBrowse link
G Ikzf1 IKAROS family zinc finger 1 ameliorates ISO protein:increased expression:liver (human) RGD PMID:25301737 RGD:150540326 NCBI chr11:11,634,970...11,722,930
Ensembl chr11:11,634,980...11,722,926 		JBrowse link
G Il10 interleukin 10 treatment ISO RGD PMID:23822114 PMID:26890368 RGD:7365006, RGD:14975171 NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711 		JBrowse link
G Il12a interleukin 12a susceptibility ISO associated with hepatitis C;DNA:SNP:3'UTR: rs568408( G>A)(human)
associated with hepatitis B; DNA:SNP, haplotype:3′UTR::rs568408(human)		 RGD PMID:27819525 PMID:20521253 PMID:26631030 RGD:25440490, RGD:25440491, RGD:25440501 NCBI chr 3:68,597,977...68,605,881
Ensembl chr 3:68,597,977...68,605,880 		JBrowse link
G Il15ra interleukin 15 receptor, alpha chain disease_progression ISO mRNA:increased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr 2:11,709,992...11,739,129
Ensembl chr 2:11,710,101...11,739,128 		JBrowse link
G Il18 interleukin 18 severity
disease_progression
susceptibility		 ISO associated with hepatitis C;DNA:SNPs, haplotype:promoter:-607C>A, -137G>C(human)
DNA:SNP:promoter:-137G>C(rs187238)(human)
associated with hepatitis B, chronic;DNA:SNP:promoter:-607C>A(human)		 RGD PMID:29341496 PMID:26893476 PMID:27429592 PMID:27470888 RGD:14695526, RGD:11538094, RGD:14695540, RGD:14696663 NCBI chr 9:50,466,000...50,493,141
Ensembl chr 9:50,466,127...50,493,140 		JBrowse link
G Il18r1 interleukin 18 receptor 1 ISO
IMP		 mRNA:decreased expression:liver RGD PMID:26893476 PMID:26893476 RGD:11538094, RGD:11538094 NCBI chr 1:40,504,712...40,540,014
Ensembl chr 1:40,504,712...40,540,014 		JBrowse link
G Il1b interleukin 1 beta susceptibility ISO DNA:polymorphism:promoter:-31T>C (human) RGD PMID:21653279 RGD:7401222 NCBI chr 2:129,206,490...129,213,059
Ensembl chr 2:129,206,490...129,213,059 		JBrowse link
G Il1rap interleukin 1 receptor accessory protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr16:26,400,259...26,548,878
Ensembl chr16:26,400,454...26,548,867 		JBrowse link
G Il1rn interleukin 1 receptor antagonist ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:24,226,872...24,241,503
Ensembl chr 2:24,226,865...24,241,506 		JBrowse link
G Il2 interleukin 2 treatment ISO RGD PMID:10933975 PMID:9449371 RGD:8693323, RGD:14747035 NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108 		JBrowse link
G Il21 interleukin 21 ISO associated with hepatitis B;DNA:SNPS, haplotype:(rs13143866, rs2221903, rs907715) (human) RGD PMID:25892873 RGD:127285359 NCBI chr 3:37,276,908...37,286,785
Ensembl chr 3:37,276,908...37,286,785 		JBrowse link
G Il6 interleukin 6 treatment
disease_progression		 ISO
IEP		 CTD Direct Evidence: marker/mechanism
DNA:SNP: :rs2069852 (human)
mRNA,protein:increased expression:liver, blood serum (mouse)		 CTD
RGD		 PMID:17615358 PMID:20818158 PMID:26297436 PMID:27022031 PMID:27368337 More... RGD:14975289, RGD:11344640 NCBI chr 5:30,218,112...30,224,973
Ensembl chr 5:30,218,112...30,224,979 		JBrowse link
G Il6st interleukin 6 signal transducer ISO RGD PMID:15780071 RGD:1626706 NCBI chr13:112,600,604...112,643,394
Ensembl chr13:112,600,604...112,646,620 		JBrowse link
G Ing3 inhibitor of growth family, member 3 treatment ISO RGD PMID:25156538 RGD:9587823 NCBI chr 6:21,948,002...21,976,037
Ensembl chr 6:21,949,570...21,976,037 		JBrowse link
G Inmt indolethylamine N-methyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 6:55,147,612...55,151,975
Ensembl chr 6:55,147,611...55,152,028 		JBrowse link
G Inpp4b inositol polyphosphate-4-phosphatase, type II ISO CTD Direct Evidence: marker/mechanism CTD PMID:29415082 NCBI chr 8:82,068,895...82,865,553
Ensembl chr 8:82,069,185...82,854,543 		JBrowse link
G Ins1 insulin I ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr19:52,252,735...52,253,453
Ensembl chr19:52,252,735...52,253,914 		JBrowse link
G Ins2 insulin II ISO associated with Chronic Hepatitis C;mRNA:decreased expression:liver (human) RGD PMID:33132693 RGD:150340613 NCBI chr 7:142,232,393...142,233,463
Ensembl chr 7:142,232,393...142,297,118 		JBrowse link
G Insr insulin receptor ISO mRNA, protein:increased expression:liver (human, rat)
human cells in a mouse model		 RGD PMID:23633480 PMID:29610518 RGD:9685423, RGD:14700930 NCBI chr 8:3,200,922...3,329,649
Ensembl chr 8:3,172,061...3,329,617 		JBrowse link
G Iqgap1 IQ motif containing GTPase activating protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20977743 NCBI chr 7:80,361,331...80,453,288
Ensembl chr 7:80,361,331...80,475,722 		JBrowse link
G Iqgap2 IQ motif containing GTPase activating protein 2 ISO
IAGP		 CTD Direct Evidence: marker/mechanism
OMIM:114550		 CTD
MouseDO		 PMID:20977743 NCBI chr13:95,763,685...96,028,788
Ensembl chr13:95,763,682...96,028,991 		JBrowse link
G Iqgap3 IQ motif containing GTPase activating protein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:87,989,309...88,028,355
Ensembl chr 3:87,989,278...88,028,355 		JBrowse link
G Irf2 interferon regulatory factor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22561517 NCBI chr 8:47,192,751...47,300,493
Ensembl chr 8:47,192,767...47,300,493 		JBrowse link
G Irs1 insulin receptor substrate 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:1311924 PMID:23958494 NCBI chr 1:82,210,826...82,269,160
Ensembl chr 1:82,210,822...82,269,137 		JBrowse link
G Irs2 insulin receptor substrate 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16127164 NCBI chr 8:11,034,681...11,058,929
Ensembl chr 8:11,034,681...11,058,458 		JBrowse link
G Itih3 inter-alpha trypsin inhibitor, heavy chain 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 NCBI chr14:30,630,529...30,645,748
Ensembl chr14:30,630,529...30,645,717 		JBrowse link
G Itih4 inter alpha-trypsin inhibitor, heavy chain 4 disease_progression ISO associated with hepatitis B;protein:decreased expression:serum RGD PMID:24836184 RGD:40903002 NCBI chr14:30,608,433...30,623,943
Ensembl chr14:30,608,433...30,624,310 		JBrowse link
G Jag1 jagged 1 ISO protein:increased expression:liver RGD PMID:30660174 RGD:14694832 NCBI chr 2:136,923,371...136,958,440
Ensembl chr 2:136,923,376...136,958,564 		JBrowse link
G Jak1 Janus kinase 1 ISO RGD PMID:23788652 RGD:150524353 NCBI chr 4:101,009,171...101,122,493
Ensembl chr 4:101,009,564...101,122,479 		JBrowse link
G Jak2 Janus kinase 2 severity
exacerbates
ameliorates
treatment		 IEP
ISO
IMP		 mRNA:decreased expression:liver (human)
protein:increased phosphorylation:liver (human)
protein:increased phosphorylation:liver (mouse)
associated with Diseases of the Aged and non-alcoholic fatty liver disease
L-JAK2 KO		 RGD PMID:25420511 PMID:22392353 PMID:22821478 PMID:31393852 PMID:28100771 More... RGD:18182928, RGD:125097525, RGD:127285621, RGD:127285655, RGD:127285675, RGD:127285672 NCBI chr19:29,229,006...29,290,495
Ensembl chr19:29,229,228...29,290,480 		JBrowse link
G Jdp2 Jun dimerization protein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20214788 NCBI chr12:85,645,190...85,686,652
Ensembl chr12:85,645,801...85,686,652 		JBrowse link
G Jun jun proto-oncogene ISO CTD Direct Evidence: marker/mechanism CTD PMID:20214788 NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459 		JBrowse link
G Jund jun D proto-oncogene ISO associated with HBV;protein:increased expression:liver (human) RGD PMID:15927205 RGD:153297768 NCBI chr 8:71,150,389...71,153,265
Ensembl chr 8:71,151,599...71,153,265 		JBrowse link
G Kat2b K(lysine) acetyltransferase 2B severity ISO protein:decreased expression:liver (human) RGD PMID:23643089 RGD:9590314 NCBI chr17:53,873,802...53,979,749
Ensembl chr17:53,873,889...53,979,748 		JBrowse link
G Kbtbd11 kelch repeat and BTB (POZ) domain containing 11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:15,059,408...15,083,333
Ensembl chr 8:15,061,025...15,083,333 		JBrowse link
G Kcnh1 potassium voltage-gated channel, subfamily H (eag-related), member 1 ISO protein:increased expression:liver (human) RGD PMID:17022810 RGD:9693723 NCBI chr 1:191,871,759...192,192,467
Ensembl chr 1:191,873,082...192,192,467 		JBrowse link
G Kcnn2 potassium intermediate/small conductance calcium-activated channel, subfamily N, member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr18:45,401,754...45,818,954
Ensembl chr18:45,401,927...45,818,950 		JBrowse link
G Kdm1a lysine (K)-specific demethylase 1A severity ISO mRNA, protein:increased expression:liver (human) RGD PMID:23236241 RGD:9681002 NCBI chr 4:136,277,844...136,330,127
Ensembl chr 4:136,277,851...136,330,034 		JBrowse link
G Kdm3a lysine (K)-specific demethylase 3A ISO mRNA:increased expression:liver (human) RGD PMID:21607773 RGD:9590222 NCBI chr 6:71,565,954...71,609,963
Ensembl chr 6:71,565,956...71,609,974 		JBrowse link
G Kdm5c lysine demethylase 5C exacerbates ISO protein:increased expression:liver (human) RGD PMID:26503415 RGD:11530160 NCBI chr  X:151,015,698...151,062,098
Ensembl chr  X:151,016,016...151,057,531 		JBrowse link
G Kdm6a lysine (K)-specific demethylase 6A ameliorates ISO human cells in a mouse model RGD PMID:32765772 RGD:150429729 NCBI chr  X:18,027,101...18,147,061
Ensembl chr  X:18,028,814...18,146,175 		JBrowse link
G Kdm8 lysine (K)-specific demethylase 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:125,043,788...125,062,823
Ensembl chr 7:125,043,848...125,061,441 		JBrowse link
G Kdr kinase insert domain protein receptor treatment
disease_progression		 ISO DNA:SNPs: :rs1870377, rs2071559, rs2305948 (human)
protein:increased expression:liver
protein:decreased expression:liver
associated with alcoholic liver cirrhosis;DNA:SNP: :1416A>T (human)		 RGD PMID:25182707 PMID:19177438 PMID:25333267 PMID:23660204 PMID:24445728 RGD:126848806, RGD:126848810, RGD:126848812, RGD:126848813, RGD:126848814 NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118 		JBrowse link
G Kif11 kinesin family member 11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr19:37,364,830...37,410,311
Ensembl chr19:37,364,851...37,410,307 		JBrowse link
G Kif14 kinesin family member 14 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:136,394,044...136,483,676
Ensembl chr 1:136,394,081...136,459,249 		JBrowse link
G Kif15 kinesin family member 15 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:122,780,146...122,847,798
Ensembl chr 9:122,780,111...122,847,798 		JBrowse link
G Kif18a kinesin family member 18A ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:109,111,165...109,172,094
Ensembl chr 2:109,111,083...109,172,092 		JBrowse link
G Kif18b kinesin family member 18B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr11:102,796,344...102,815,960
Ensembl chr11:102,796,355...102,815,950 		JBrowse link
G Kif1b kinesin family member 1B severity
susceptibility		 ISO mRNA, protein:decreased expression:liver (human)
DNA:snp:intron:c.2537+518A>G (rs17401966) (human)		 RGD PMID:26217094 PMID:27122668 RGD:11052488, RGD:12738461 NCBI chr 4:149,260,776...149,392,762
Ensembl chr 4:149,260,776...149,392,150 		JBrowse link
G Kif20a kinesin family member 20A ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr18:34,757,677...34,766,330
Ensembl chr18:34,757,666...34,766,330 		JBrowse link
G Kif23 kinesin family member 23 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:61,824,559...61,854,078
Ensembl chr 9:61,823,187...61,854,056 		JBrowse link
G Kif2c kinesin family member 2C ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:117,016,830...117,039,821
Ensembl chr 4:117,016,836...117,039,836 		JBrowse link
G Kif4 kinesin family member 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr  X:99,669,693...99,770,878
Ensembl chr  X:99,669,343...99,770,820 		JBrowse link
G Kifc1 kinesin family member C1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr17:34,094,640...34,109,607
Ensembl chr17:34,094,633...34,109,635 		JBrowse link
G Klf4 Kruppel-like transcription factor 4 (gut) disease_progression
treatment		 ISO RGD PMID:22677193 PMID:22677193 RGD:14402023, RGD:14402023 NCBI chr 4:55,527,137...55,536,984
Ensembl chr 4:55,527,143...55,532,466 		JBrowse link
G Klrb1 killer cell lectin-like receptor subfamily B member 1 disease_progression ISO mRNA:decreased expression:liver (human) RGD PMID:35693827 RGD:153344586 NCBI chr 6:128,683,056...128,701,293
Ensembl chr 6:128,682,799...128,700,022 		JBrowse link
G Kmt2a lysine (K)-specific methyltransferase 2A ISO CTD Direct Evidence: marker/mechanism CTD PMID:22634756 NCBI chr 9:44,714,652...44,793,492
Ensembl chr 9:44,714,652...44,792,594 		JBrowse link
G Kmt2b lysine (K)-specific methyltransferase 2B ISO DNA:insertions, translocations:intron:IVS3, multiple (human)
CTD Direct Evidence: marker/mechanism		 CTD
RGD		 PMID:22634754 PMID:18320596 RGD:9588597 NCBI chr 7:30,268,280...30,288,371
Ensembl chr 7:30,268,283...30,288,151 		JBrowse link
G Kmt2c lysine (K)-specific methyltransferase 2C ISO CTD Direct Evidence: marker/mechanism CTD PMID:22634756 NCBI chr 5:25,476,793...25,703,853
Ensembl chr 5:25,476,796...25,703,781 		JBrowse link
G Kras Kirsten rat sarcoma viral oncogene homolog induced ISO CTD Direct Evidence: marker/mechanism
aflatoxin B1 induced:DNA:transversion,transition mutations:cds:
mRNA,protein:increased expression:liver
ClinVar Annotator: match by term: Hepatocellular cancer		 CTD
ClinVar
RGD		 PMID:2278970 PMID:3122217 PMID:11286481 PMID:11563603 PMID:12460918 More... RGD:11568697, RGD:14398750 NCBI chr 6:145,162,425...145,197,631
Ensembl chr 6:145,162,425...145,195,965 		JBrowse link
G Krt18 keratin 18 IAGP OMIM:114550 MouseDO NCBI chr15:101,936,651...101,940,461
Ensembl chr15:101,936,615...101,940,462 		JBrowse link
G Lcat lecithin cholesterol acyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:106,666,183...106,670,034
Ensembl chr 8:106,666,183...106,670,014 		JBrowse link
G Lect2 leukocyte cell-derived chemotaxin 2 ameliorates IEP
ISO		 protein:increased expression:blood serum (mouse)
protein:increased expression:blood serum (human)
human cells in mouse model		 RGD PMID:24892551 PMID:24892551 PMID:21394108 RGD:153323333, RGD:153323333, RGD:153323335 NCBI chr13:56,676,772...56,696,373
Ensembl chr13:56,690,277...56,696,315 		JBrowse link
G Lep leptin susceptibility
severity		 IAGP
IEP		 DNA:SNP:enhancer:-2548G>A (rs7799039) (human)
protein:increased expression:liver (human)		 RGD PMID:28452232 PMID:18573568 RGD:15039399, RGD:25330348 NCBI chr 6:29,060,220...29,073,875
Ensembl chr 6:29,060,219...29,073,876 		JBrowse link
G Lepr leptin receptor susceptibility ISO associated with Hepatitis B, Chronic;DNA:SNPs:cds:p.Gln223Arg, Lys109Arg (human) RGD PMID:23090836 RGD:21079466 NCBI chr 4:101,574,393...101,676,375
Ensembl chr 4:101,574,601...101,672,549 		JBrowse link
G Letm1 leucine zipper-EF-hand containing transmembrane protein 1 ISO CTD Direct Evidence: therapeutic CTD PMID:23392203 NCBI chr 5:33,897,017...33,940,061
Ensembl chr 5:33,897,017...33,940,161 		JBrowse link
G Lifr LIF receptor alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr15:7,120,091...7,226,970
Ensembl chr15:7,120,095...7,226,970 		JBrowse link
G LOC110806267 Tert 5' regulatory region ISO ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar PMID:28492532 PMID:28677271 NCBI chr13:73,770,663...73,775,510 JBrowse link
G Loxl3 lysyl oxidase-like 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35841383 NCBI chr 6:83,011,186...83,029,547
Ensembl chr 6:83,011,154...83,029,543 		JBrowse link
G Lpar1 lysophosphatidic acid receptor 1 ISO RGD PMID:19000703 RGD:2317680 NCBI chr 4:58,435,252...58,554,601
Ensembl chr 4:58,435,255...58,553,898 		JBrowse link
G Lrat lecithin-retinol acyltransferase (phosphatidylcholine-retinol-O-acyltransferase) ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 3:82,799,889...82,811,281
Ensembl chr 3:82,799,886...82,811,280 		JBrowse link
G Lrp1b low density lipoprotein-related protein 1B exacerbates ISO protein:increased expression:liver (human)
DNA:mutations:multiple: (human)		 RGD PMID:33324588 PMID:33391418 RGD:150429776, RGD:150429785 NCBI chr 2:40,485,302...42,543,747
Ensembl chr 2:40,485,258...42,543,636 		JBrowse link
G Lrrc1 leucine rich repeat containing 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:77,338,103...77,453,749
Ensembl chr 9:77,338,105...77,452,152 		JBrowse link
G Lrrc56 leucine rich repeat containing 56 ISO ClinVar Annotator: match by term: Hepatocellular cancer | ClinVar Annotator: match by term: Hepatocellular carcinoma ClinVar PMID:11150980 PMID:12835555 PMID:16155195 PMID:16170316 PMID:16329078 More... NCBI chr 7:140,774,024...140,789,968
Ensembl chr 7:140,774,070...140,789,968 		JBrowse link
G Lrrc59 leucine rich repeat containing 59 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30705370 NCBI chr11:94,520,603...94,536,049
Ensembl chr11:94,520,593...94,536,042 		JBrowse link
G Lyve1 lymphatic vessel endothelial hyaluronan receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:110,449,814...110,462,160
Ensembl chr 7:110,449,814...110,462,446 		JBrowse link
G Lztr1 leucine-zipper-like transcriptional regulator, 1 ISO DNA:missense mutation:cds, liver (human) RGD PMID:28622513 RGD:151893487 NCBI chr16:17,326,124...17,344,197
Ensembl chr16:17,326,552...17,344,197 		JBrowse link
G Mad2l1 MAD2 mitotic arrest deficient-like 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 6:66,512,205...66,518,091
Ensembl chr 6:66,512,374...66,524,204 		JBrowse link
G Magea3 MAGE family member A3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr  X:153,731,176...153,742,027
Ensembl chr  X:153,731,539...153,732,501 		JBrowse link
G Magea5 MAGE family member A5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr  X:153,836,057...153,846,147
Ensembl chr  X:153,836,057...153,846,141 		JBrowse link
G Magea6 MAGE family member A6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr  X:153,706,891...153,719,070
Ensembl chr  X:153,707,008...153,718,983 		JBrowse link
G Magec2 MAGE family member C2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr  X:61,326,566...61,335,690
Ensembl chr  X:61,327,105...61,335,684 		JBrowse link
G Malat1 metastasis associated lung adenocarcinoma transcript 1 (non-coding RNA) ISO CTD Direct Evidence: marker/mechanism CTD PMID:26735578 NCBI chr19:5,845,718...5,852,700
Ensembl chr19:5,845,717...5,852,706 		JBrowse link
G Map2k2 mitogen-activated protein kinase kinase 2 exacerbates ISO mRNA:increased expression:liver (human)
protein:increased expression:liver, cytosol (rat)		 RGD PMID:33553243 PMID:9397988 RGD:150530475, RGD:150530477 NCBI chr10:80,941,749...80,960,531
Ensembl chr10:80,941,749...80,969,809 		JBrowse link
G Map2k4 mitogen-activated protein kinase kinase 4 ISO protein:decreased expression:liver (human) RGD PMID:32850377 RGD:150429765 NCBI chr11:65,579,070...65,679,185
Ensembl chr11:65,579,069...65,679,123 		JBrowse link
G Map3k1 mitogen-activated protein kinase kinase kinase 1 exacerbates ISO mRNA:decreased expression:liver (human) RGD PMID:31310010 RGD:150573714 NCBI chr13:111,882,962...111,954,803
Ensembl chr13:111,882,962...111,945,527 		JBrowse link
G Map3k8 mitogen-activated protein kinase kinase kinase 8 ameliorates IMP RGD PMID:26560698 RGD:11342977 NCBI chr18:4,331,325...4,352,978
Ensembl chr18:4,331,327...4,353,015 		JBrowse link
G Map4k4 mitogen-activated protein kinase kinase kinase kinase 4 ameliorates
severity
treatment		 ISO human cell line in a mouse model
human recombinant gene and cell line in a mouse model		 RGD PMID:21196414 PMID:27010469 PMID:31922225 RGD:151347673, RGD:151347674, RGD:151347839 NCBI chr 1:39,939,806...40,065,470
Ensembl chr 1:39,940,073...40,065,470 		JBrowse link
G Mapk1 mitogen-activated protein kinase 1 ISO protein:increased expression:liver RGD PMID:27468214 RGD:401976278 NCBI chr16:16,801,246...16,865,317
Ensembl chr16:16,801,246...16,865,317 		JBrowse link
G Mapk14 mitogen-activated protein kinase 14 treatment
exacerbates		 IMP RGD PMID:25216638 PMID:23271722 RGD:151665347, RGD:151665348 NCBI chr17:28,910,316...28,967,379
Ensembl chr17:28,910,303...28,967,380 		JBrowse link
G Mapk8 mitogen-activated protein kinase 8 ameliorates ISO protein:decreased phosphorylation:liver (human) RGD PMID:33875785 RGD:150340688 NCBI chr14:33,099,855...33,169,213
Ensembl chr14:33,099,855...33,169,115 		JBrowse link
G Mapt microtubule-associated protein tau ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr11:104,120,235...104,222,916
Ensembl chr11:104,122,216...104,222,916 		JBrowse link
G Marco macrophage receptor with collagenous structure ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:120,402,267...120,432,753
Ensembl chr 1:120,402,267...120,432,753 		JBrowse link
G Mat1a methionine adenosyltransferase 1A ISO CTD Direct Evidence: marker/mechanism CTD PMID:12060674 NCBI chr14:40,826,969...40,846,385
Ensembl chr14:40,826,992...40,846,369 		JBrowse link
G Mbl2 mannose-binding lectin (protein C) 2 severity
susceptibility
no_association		 ISO associated with hepatitis C;DNA:SNP: :221C>G(rs709620)(human)
associated with hepatitis B-related cirrhosis;DNA:SNP: :rs11003123(G>A)(human)
associated with viral hepatitis;DNA:polymorphisms:exon:
DNA:SNPs:promoter:rs7096206(human)
protein:decreased expression:plasma
associated with hepatitis B;DNA:SNP:exon:		 RGD PMID:21733090 PMID:27298104 PMID:18221301 PMID:25787238 PMID:27557564 More... RGD:14696813, RGD:14696814, RGD:14696829, RGD:14696833, RGD:14696835, RGD:14696836 NCBI chr19:30,210,306...30,217,087
Ensembl chr19:30,210,342...30,217,087 		JBrowse link
G Mbtps1 membrane-bound transcription factor peptidase, site 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14563831 NCBI chr 8:120,234,890...120,285,603
Ensembl chr 8:120,234,895...120,285,474 		JBrowse link
G Mbtps2 membrane-bound transcription factor peptidase, site 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14563831 NCBI chr  X:156,330,818...156,381,711
Ensembl chr  X:156,318,367...156,381,711 		JBrowse link
G Mcm10 minichromosome maintenance 10 replication initiation factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:4,995,535...5,017,602
Ensembl chr 2:4,994,525...5,017,602 		JBrowse link
G Mcm2 minichromosome maintenance complex component 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 6:88,860,456...88,875,762
Ensembl chr 6:88,860,456...88,875,762 		JBrowse link
G Mcm7 minichromosome maintenance complex component 7 susceptibility IAGP
IEP		 associated with hepatitis B;DNA:SNP:promoter: (rs999885) (human)
associated with hepatitis B;miRNA:increased expression:liver (human)		 RGD PMID:24416400 PMID:27298561 RGD:15042885, RGD:15042853 NCBI chr 5:138,162,845...138,170,675
Ensembl chr 5:138,162,845...138,170,684 		JBrowse link
G Mcm9 minichromosome maintenance 9 homologous recombination repair factor IAGP OMIM:114550 MouseDO NCBI chr10:53,412,411...53,507,251
Ensembl chr10:53,412,411...53,506,535 		JBrowse link
G Mdm2 transformed mouse 3T3 cell double minute 2 susceptibility ISO DNA:transversion:promoter:g.-309T>G (human) RGD PMID:20019189 RGD:2317357 NCBI chr10:117,524,780...117,546,663
Ensembl chr10:117,524,780...117,546,663 		JBrowse link
G Me1 malic enzyme 1, NADP(+)-dependent, cytosolic ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147110 NCBI chr 9:86,463,416...86,577,967
Ensembl chr 9:86,463,424...86,578,006 		JBrowse link
G Mecp2 methyl CpG binding protein 2 ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:liver		 CTD
RGD		 PMID:26189965 PMID:11844796 RGD:2289670 NCBI chr  X:73,070,198...73,129,296
Ensembl chr  X:73,070,198...73,129,296 		JBrowse link
G Med1 mediator complex subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20007298 NCBI chr11:98,042,980...98,084,121
Ensembl chr11:98,042,980...98,084,119 		JBrowse link
G Melk maternal embryonic leucine zipper kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:44,300,876...44,364,301
Ensembl chr 4:44,300,876...44,364,675 		JBrowse link
G Met met proto-oncogene severity
susceptibility		 ISO
IMP		 protein:increased expression:liver (rat)
mRNA:increased expression:liver, carcinoma (human)
CTD Direct Evidence: marker/mechanism
protein:increased expression:liver (human)
ClinVar Annotator: match by term: Hepatocellular cancer		 CTD
ClinVar
OMIM
RGD		 PMID:21774103 PMID:21970370 PMID:22703879 PMID:24728327 PMID:25741868 More... RGD:2317495, RGD:1600123, RGD:2317575, RGD:152995524, RGD:152995524 NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979 		JBrowse link
G Mfsd2a MFSD2 lysolipid transporter A, lysophospholipid ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:122,840,643...122,855,844
Ensembl chr 4:122,840,643...122,854,981 		JBrowse link
G Mir106b microRNA 106b disease_progression
severity		 IEP miRNA:decreased expression:liver (human)
miRNA:increased expression:plasma (human)
miRNA:increased expression:serum (human)
miRNA:increased expression:liver (human)		 RGD PMID:28958640 PMID:25894380 PMID:28611524 PMID:31406464 RGD:15042874, RGD:15042875, RGD:15042876, RGD:15042877 NCBI chr 5:138,163,999...138,164,080
Ensembl chr 5:138,163,999...138,164,080 		JBrowse link
G Mir107 microRNA 107 treatment
onset		 ISO RNA:decreased expression:liver:
RNA:increased expression:liver:		 RGD PMID:30738047 PMID:27773820 PMID:26191213 PMID:28079796 RGD:14975277, RGD:14975278, RGD:11066920, RGD:14975300 NCBI chr19:34,798,087...34,798,173
Ensembl chr19:34,798,087...34,798,173 		JBrowse link
G Mir122 microRNA 122 severity ISO CTD Direct Evidence: marker/mechanism
associated with hepatitis B miRNA:decreased expression:liver
protein:decreased expression:liver (human)
mRNA:decreased expression:blood (human)		 CTD
RGD		 PMID:16924677 PMID:25269820 PMID:25422324 PMID:19584283 PMID:27528885 RGD:14394424, RGD:14401603, RGD:151356981, RGD:151361113 NCBI chr18:65,381,932...65,381,997
Ensembl chr18:65,381,932...65,381,997 		JBrowse link
G Mir125a microRNA 125a treatment
severity		 IEP
ISO		 RNA:increased expression:liver: RGD PMID:30257386 PMID:30257386 PMID:29951066 RGD:21403677, RGD:21403677, RGD:21403679 NCBI chr17:18,051,074...18,051,141
Ensembl chr17:18,051,074...18,051,141 		JBrowse link
G Mir127 microRNA 127 ISO miRNA:decreased expression:liver (human) RGD PMID:24854842 RGD:152995355 NCBI chr12:109,559,280...109,559,349
Ensembl chr12:109,559,280...109,559,349 		JBrowse link
G Mir130b microRNA 130b severity ISO miRNA:increased expression:liver RGD PMID:25387077 RGD:14694845 NCBI chr16:16,941,925...16,942,006
Ensembl chr16:16,941,925...16,942,006 		JBrowse link
G Mir133a-1 microRNA 133a-1 disease_progression ISO mRNA:decreased expression:liver (human)
human cells in mouse model		 RGD PMID:30086463 PMID:30086463 RGD:153344517, RGD:153344517 NCBI chr18:10,782,909...10,782,976
Ensembl chr18:10,782,909...10,782,976 		JBrowse link
G Mir133b microRNA 133b severity ISO mRNA:decreased expression:liver(human) RGD PMID:30391496 RGD:155804298 NCBI chr 1:20,752,993...20,753,111
Ensembl chr 1:20,752,993...20,753,111 		JBrowse link
G Mir136 microRNA 136 exacerbates ISO RNA:decreased expression:liver (human) RGD PMID:28849100 RGD:153345547 NCBI chr12:109,561,761...109,561,822
Ensembl chr12:109,561,761...109,561,822 		JBrowse link
G Mir139 microRNA 139 ISO RNA:decreased expression:liver (human) RGD PMID:30710422 RGD:153344549 NCBI chr 7:101,124,583...101,124,650
Ensembl chr 7:101,124,583...101,124,650 		JBrowse link
G Mir145a microRNA 145a severity IEP miRNA:decreased expression:liver (human) RGD PMID:30572504 RGD:15039395 NCBI chr18:61,780,896...61,780,965
Ensembl chr18:61,780,896...61,780,965 		JBrowse link
G Mir146 microRNA 146 sexual_dimorphism
susceptibility		 ISO associated with hepatitis B;miRNA:SNP:exon: (rs2910164) (human)
miRNA:SNP: (human)
associated with hepatitis B;miRNA:SNP: (human)		 RGD PMID:18711148 PMID:24816919 PMID:24615520 RGD:126925148, RGD:126925158, RGD:126925187 NCBI chr11:43,265,224...43,265,288
Ensembl chr11:43,265,224...43,265,288 		JBrowse link
G Mir150 microRNA 150 ISO mRNA:decreased expression:liver (human) RGD PMID:30205391 RGD:153344577 NCBI chr 7:44,771,181...44,771,245
Ensembl chr 7:44,771,181...44,771,245 		JBrowse link
G Mir152 microRNA 152 disease_progression ISO miRNA:decreased expression:liver RGD PMID:30967300 PMID:26531720 RGD:19165146, RGD:21066331 NCBI chr11:96,741,219...96,741,291
Ensembl chr11:96,741,219...96,741,291 		JBrowse link
G Mir154 microRNA 154 ISO RNA:decreased expression:liver (human) RGD PMID:33195697 RGD:152995478 NCBI chr12:109,704,867...109,704,932
Ensembl chr12:109,704,867...109,704,932 		JBrowse link
G Mir155 microRNA 155 disease_progression ISO miRNA:decreased expression:peripheral blood mononuclear cell
miRNA:increased expression:serum
associated with hepatitis C;DNA:SNP: :rs767649 (human)		 RGD PMID:27035278 PMID:27035278 PMID:28074870 PMID:30710754 PMID:29528577 More... RGD:21079433, RGD:21079433, RGD:21079477, RGD:21081523, RGD:24922222, RGD:25671465 NCBI chr16:84,511,028...84,511,092
Ensembl chr16:84,511,028...84,511,092 		JBrowse link
G Mir18 microRNA 18 severity IEP miRNA:increased expression:liver (human)
associated with hepatitis B;miRNA:increased expression:liver (human)
associated with Hepatitis C, Chronic;miRNA:increased expression:serum (human)		 RGD PMID:19027010 PMID:30519035 PMID:30191950 PMID:24975878 PMID:29455432 RGD:15039398, RGD:15039400, RGD:15039389, RGD:15039401, RGD:15039404 NCBI chr14:115,281,283...115,281,378
Ensembl chr14:115,281,283...115,281,378 		JBrowse link
G Mir181c microRNA 181c IEP miRNA:decreased expression:liver (human) RGD PMID:31114379 RGD:15042894 NCBI chr 8:84,905,502...84,905,590
Ensembl chr 8:84,905,502...84,905,590 		JBrowse link
G Mir18b microRNA 18b severity IEP miRNA:increased expression:liver (human) RGD PMID:23496901 RGD:15039403 NCBI chr  X:51,831,208...51,831,290
Ensembl chr  X:51,831,208...51,831,290 		JBrowse link
G Mir193a microRNA 193a disease_progression
exacerbates		 ISO miRNA:decreased expression:liver (human)
RNA:increased expression:blood serum (human)
DNA:hypomethylation		 RGD PMID:26263159 PMID:30710422 PMID:32960907 PMID:28036298 RGD:11070076, RGD:153344549, RGD:153344563, RGD:153344564 NCBI chr11:79,602,795...79,602,860
Ensembl chr11:79,602,795...79,602,860 		JBrowse link
G Mir195a microRNA 195a severity IEP
IMP		 miRNA:decreased expression:liver (human)
miRNA:decreased expression:liver (mouse)		 RGD PMID:25607636 PMID:25607636 RGD:15042896, RGD:15042896 NCBI chr11:70,125,868...70,125,961
Ensembl chr11:70,125,868...70,125,961 		JBrowse link
G Mir196a-2 microRNA 196a-2 susceptibility ISO associated with hepatitis B, chronic; DNA:SNP: : (rs12304647)
DNA:SNP: : (rs11614913)		 RGD PMID:21692953 PMID:24248733 RGD:14401594 RGD:14401595 NCBI chr15:102,881,785...102,881,869
Ensembl chr15:102,881,785...102,881,869 		JBrowse link
G Mir199b microRNA 199b disease_progression ISO miRNA:decreased expression:liver RGD PMID:30536310 RGD:14694833 NCBI chr 2:32,208,472...32,208,581
Ensembl chr 2:32,208,472...32,208,581 		JBrowse link
G Mir200b microRNA 200b treatment
disease_progression		 ISO mRNA:decreased expression:liver
DNA:hypermethylation:promoter		 RGD PMID:26919246 PMID:26919246 PMID:28383782 PMID:28383782 PMID:28383782 RGD:14928318, RGD:14928318, RGD:14928322, RGD:14928322, RGD:14928322 NCBI chr 4:156,140,138...156,140,207
Ensembl chr 4:156,140,138...156,140,207 		JBrowse link
G Mir20a microRNA 20a ISO associated with Human Viral Hepatitis RGD PMID:30623908 RGD:25823145 NCBI chr14:115,281,589...115,281,695
Ensembl chr14:115,281,589...115,281,695 		JBrowse link
G Mir212 microRNA 212 disease_progression
ameliorates		 ISO RGD PMID:25965836 PMID:25965836 RGD:11054501, RGD:11054501 NCBI chr11:75,064,214...75,064,304
Ensembl chr11:75,064,214...75,064,304 		JBrowse link
G Mir21a microRNA 21a severity
treatment		 ISO miRNA:increased expression:liver RGD PMID:20447717 PMID:24963487 PMID:21749846 RGD:14695022, RGD:40925952, RGD:41404642 NCBI chr11:86,474,893...86,474,984
Ensembl chr11:86,474,893...86,474,984 		JBrowse link
G Mir22 microRNA 22 severity
disease_progression		 ISO in male; RNA:increased expression:liver: RGD PMID:23766411 PMID:27811373 PMID:21750200 RGD:14700874, RGD:14700875, RGD:14700876 NCBI chr11:75,354,542...75,354,636
Ensembl chr11:75,354,542...75,354,636 		JBrowse link
G Mir221 microRNA 221 disease_progression
treatment		 ISO
IEP		 RGD PMID:25817558 PMID:29713162 PMID:29713162 PMID:22009537 PMID:28096271 More... RGD:11086123, RGD:18337267, RGD:18337267, RGD:18337273, RGD:18337275, RGD:18337275, RGD:18337275, RGD:151893509 NCBI chr  X:19,012,533...19,012,627
Ensembl chr  X:19,012,533...19,012,627 		JBrowse link
G Mir222 microRNA 222 disease_progression
severity		 ISO RGD PMID:24124720 PMID:20103675 RGD:151709003, RGD:151709004 NCBI chr  X:19,013,132...19,013,210
Ensembl chr  X:19,013,132...19,013,210 		JBrowse link
G Mir223 microRNA 223 disease_progression IMP
ISO		 associated with high-fat diet,
associated with Chronic HepatitisC; RNA:decreased expression:serum:
associated with Chronic Hepatitis B; RNA:decreased expression:serum:
RNA:increased expression:serum:		 RGD PMID:30964207 PMID:28982915 PMID:25391771 PMID:24595450 PMID:21229610 RGD:21408549, RGD:21408578, RGD:21408580, RGD:21408583, RGD:21408591 NCBI chr  X:95,286,423...95,286,532
Ensembl chr  X:95,286,423...95,286,532 		JBrowse link
G Mir224 microRNA 224 severity IEP miRNA:increased expression:liver (human)
associated with hepatitis B;miRNA:increased expression:liver (human)
miRNA:increased expression:plasma (human)		 RGD PMID:23922662 PMID:22459148 PMID:23913306 PMID:24923856 PMID:27462777 RGD:18182921, RGD:18182922, RGD:18182923, RGD:18182924, RGD:18182926 NCBI chr  X:71,304,637...71,304,718
Ensembl chr  X:71,304,637...71,304,718 		JBrowse link
G Mir23a microRNA 23a ISO miRNA:increased expression:liver RGD PMID:22318941 RGD:14694846 NCBI chr 8:84,935,147...84,935,221
Ensembl chr 8:84,935,147...84,935,221 		JBrowse link
G Mir23b microRNA 23b ISO DNA:hypermethylation RGD PMID:28036298 RGD:153344564 NCBI chr13:63,448,298...63,448,371
Ensembl chr13:63,448,298...63,448,371 		JBrowse link
G Mir25 microRNA 25 severity IEP miRNA:increased expression:liver (human)
associated with hepatitis B;miRNA:increased expression:serum (human)
associated with hepatitis B;miRNA:increased expression:liver (human)		 RGD PMID:30191950 PMID:24593846 PMID:21098710 PMID:27298561 RGD:15039389, RGD:15042897, RGD:15042899, RGD:15042853 NCBI chr 5:138,163,583...138,163,666
Ensembl chr 5:138,163,583...138,163,666 		JBrowse link
G Mir27a microRNA 27a severity
treatment		 ISO human cell line in a mouse model
human miRNA and cell line in a mouse model		 RGD PMID:29143999 PMID:30083261 RGD:14696659, RGD:14696660 NCBI chr 8:84,935,301...84,935,387
Ensembl chr 8:84,935,301...84,935,387 		JBrowse link
G Mir29a microRNA 29a severity ISO associated with hepatitis B;miRNA:increased expression:liver (human) RGD PMID:23285022 PMID:23285022 RGD:15042850, RGD:15042850 NCBI chr 6:31,039,595...31,039,682
Ensembl chr 6:31,039,595...31,039,682 		JBrowse link
G Mir302d microRNA 302d ameliorates ISO Human cells in mouse model RGD PMID:28352351 RGD:152998975 NCBI chr 3:127,339,273...127,339,338
Ensembl chr 3:127,339,273...127,339,338 		JBrowse link
G Mir31 microRNA 31 severity ISO RNA:decreased expression:liver (human)
miRNA:decreased expression:liver (human)
miRNA:decreased expression:liver (rat)		 RGD PMID:28623129 PMID:25797269 PMID:25797269 RGD:152998991, RGD:11085965, RGD:11085965 NCBI chr 4:88,828,794...88,828,899
Ensembl chr 4:88,828,794...88,828,899 		JBrowse link
G Mir340 microRNA 340 ISO miRNA:decreased expression:liver RGD PMID:27998770 RGD:18936991 NCBI chr11:49,960,529...49,960,626
Ensembl chr11:49,960,529...49,960,626 		JBrowse link
G Mir34a microRNA 34a treatment ISO human cell line in a mouse model
miRNA:decreased expression:liver		 RGD PMID:25217526 PMID:29328457 RGD:14694835, RGD:14694836 NCBI chr 4:150,152,911...150,153,012
Ensembl chr 4:150,152,911...150,153,012 		JBrowse link
G Mir411 microRNA 411 disease_progression ISO mRNA:decreased expression:liver (human) RGD PMID:30086881 RGD:152999437 NCBI chr12:109,676,609...109,676,690
Ensembl chr12:109,676,609...109,676,690 		JBrowse link
G Mir432 microRNA 432 disease_progression ISO mRNA:decreased expression:liver (human) RGD PMID:25797263 PMID:33675609 PMID:30086881 RGD:11087457, RGD:152999436, RGD:152999437 NCBI chr12:109,561,390...109,561,464
Ensembl chr12:109,561,390...109,561,464 		JBrowse link
G Mir455 microRNA 455 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35286011 NCBI chr 4:63,175,088...63,175,169
Ensembl chr 4:63,175,088...63,175,169 		JBrowse link
G Mir494 microRNA 494 disease_progression ISO RGD PMID:25820676 RGD:155900754 NCBI chr12:109,681,752...109,681,836
Ensembl chr12:109,681,752...109,681,836 		JBrowse link
G Mir539 microRNA 539 ISO CTD Direct Evidence: therapeutic CTD PMID:27717846 NCBI chr12:109,694,563...109,694,636
Ensembl chr12:109,694,563...109,694,636 		JBrowse link
G Mir615 microRNA 615 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22819824 NCBI chr15:102,923,342...102,923,433
Ensembl chr15:102,923,342...102,923,433 		JBrowse link
G Mir665 microRNA 665 disease_progression ISO mRNA:increased expression:liver (human)
associated with metastasis; human cells in mouse model		 RGD PMID:30237408 PMID:30237408 RGD:151361293, RGD:151361293 NCBI chr12:109,552,748...109,552,841
Ensembl chr12:109,552,748...109,552,841 		JBrowse link
G Mir93 microRNA 93 severity IEP associated with hepatitis B;miRNA:increased expression:liver (human) RGD PMID:27298561 PMID:28592130 RGD:15042853, RGD:15042900 NCBI chr 5:138,163,785...138,163,872
Ensembl chr 5:138,163,785...138,163,872 		JBrowse link
G Mir96 microRNA 96 severity IEP miRNA:increased expression:liver (human) RGD PMID:28892647 PMID:25813403 RGD:15042901, RGD:15042902 NCBI chr 6:30,169,445...30,169,550
Ensembl chr 6:30,169,445...30,169,550 		JBrowse link
G Mirlet7c-1 microRNA let7c-1 ISO miRNA:decreased expression:liver RGD PMID:22289550 RGD:14695021 NCBI chr16:77,396,545...77,396,638
Ensembl chr16:77,396,545...77,396,638 		JBrowse link
G Mki67 antigen identified by monoclonal antibody Ki 67 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:135,291,513...135,318,286
Ensembl chr 7:135,291,513...135,318,090 		JBrowse link
G Mlxipl MLX interacting protein-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147110 NCBI chr 5:135,118,744...135,168,622
Ensembl chr 5:135,118,744...135,167,236 		JBrowse link
G Mme membrane metallo endopeptidase ISO RGD PMID:8302012 RGD:13801035 NCBI chr 3:63,202,632...63,291,134
Ensembl chr 3:63,148,958...63,293,451 		JBrowse link
G Mmp14 matrix metallopeptidase 14 (membrane-inserted) ISO CTD Direct Evidence: marker/mechanism CTD PMID:33010264 NCBI chr14:54,669,055...54,679,913
Ensembl chr14:54,669,069...54,682,821 		JBrowse link
G Mmp2 matrix metallopeptidase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20084675 NCBI chr 8:93,553,920...93,580,049
Ensembl chr 8:93,553,919...93,580,048 		JBrowse link
G Mmp9 matrix metallopeptidase 9 IMP
ISO		 CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:20084675 PMID:21681821 RGD:8547864 NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770 		JBrowse link
G Mogat2 monoacylglycerol O-acyltransferase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 7:98,868,291...98,887,818
Ensembl chr 7:98,868,291...98,887,826 		JBrowse link
G Mpl myeloproliferative leukemia virus oncogene IMP human cells in mouse model RGD PMID:23157389 RGD:126925755 NCBI chr 4:118,299,609...118,314,771
Ensembl chr 4:118,299,612...118,314,710 		JBrowse link
G Mpo myeloperoxidase susceptibility
disease_progression		 ISO CTD Direct Evidence: marker/mechanism
associated with liver cirrhosis; DNA:SNP:promoter:-463G>A( rs2333227)(human)
associated with liver cirrhosis with Hepatitis C;DNA:SNP:promoter:-463G>A(human)		 CTD
RGD		 PMID:19731237 PMID:19731237 PMID:21907168 RGD:26923907, RGD:27095879 NCBI chr11:87,684,610...87,695,238
Ensembl chr11:87,684,407...87,695,239 		JBrowse link
G Mro maestro ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr18:73,992,465...74,014,405
Ensembl chr18:73,992,456...74,014,404 		JBrowse link
G Msh3 mutS homolog 3 ISO ClinVar Annotator: match by term: Hepatocellular cancer ClinVar PMID:28492532 NCBI chr13:92,348,387...92,491,515
Ensembl chr13:92,348,380...92,491,511 		JBrowse link
G Msh5 mutS homolog 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr17:35,247,581...35,267,842
Ensembl chr17:35,247,581...35,265,721 		JBrowse link
G mt-Co1 cytochrome c oxidase I, mitochondrial ISO RGD PMID:2548155 RGD:2302301 NCBI chr MT:5,328...6,872
Ensembl chr MT:5,328...6,872 		JBrowse link
G mt-Nd5 NADH dehydrogenase 5, mitochondrial ISO mRNA:increased expression:liver RGD PMID:2507335 RGD:2302316 NCBI chr MT:11,742...13,565
Ensembl chr MT:11,742...13,565 		JBrowse link
G Mt2 metallothionein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17363595 PMID:28284560 NCBI chr 8:94,899,246...94,900,195
Ensembl chr 8:94,899,292...94,900,196 		JBrowse link
G Mtbp Mdm2, transformed 3T3 cell double minute p53 binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:29765550 NCBI chr15:55,420,800...55,489,819
Ensembl chr15:55,420,804...55,489,819 		JBrowse link
G Mtdh metadherin treatment ISO human cells in a mouse model RGD PMID:26351209 RGD:11096879 NCBI chr15:34,082,613...34,143,683
Ensembl chr15:34,082,840...34,145,770 		JBrowse link
G Mthfd2 methylenetetrahydrofolate dehydrogenase (NAD+ dependent), methenyltetrahydrofolate cyclohydrolase ISO mRNA:increased expression:liver RGD PMID:3878730 RGD:2302305 NCBI chr 6:83,282,686...83,302,926
Ensembl chr 6:83,282,673...83,302,890 		JBrowse link
G Mthfr methylenetetrahydrofolate reductase susceptibility
disease_progression
onset		 ISO DNA:SNP,haplotype: :677C>T, 1298A>C(human)
DNA:SNP: :677C>T(human)
DNA:SNP: :1298A>C(human)
DNA:SNPs: :677C>T, 1298A>C(human)		 RGD PMID:17503006 PMID:23996892 PMID:19035314 PMID:17659576 RGD:14696703, RGD:14696704, RGD:14696707, RGD:14696708 NCBI chr 4:148,123,534...148,144,019
Ensembl chr 4:148,123,534...148,144,008 		JBrowse link
G Mtor mechanistic target of rapamycin kinase severity ISO CTD Direct Evidence: marker/mechanism
mRNA, protein:increased expression:liver (human)		 CTD
RGD		 PMID:21147110 PMID:25371154 RGD:152995471 NCBI chr 4:148,533,039...148,642,142
Ensembl chr 4:148,533,068...148,642,140 		JBrowse link
G Mtrr 5-methyltetrahydrofolate-homocysteine methyltransferase reductase susceptibility ISO DNA:SNP: :66A>G(human) RGD PMID:19035314 RGD:14696707 NCBI chr13:68,708,897...68,730,273
Ensembl chr13:68,708,899...68,730,268 		JBrowse link
G Mvk mevalonate kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147110 NCBI chr 5:114,582,324...114,598,652
Ensembl chr 5:114,582,330...114,598,652 		JBrowse link
G Mybl2 myeloblastosis oncogene-like 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:162,896,246...162,926,608
Ensembl chr 2:162,896,607...162,926,608 		JBrowse link
G Myc myelocytomatosis oncogene treatment
severity		 IMP
ISO
IAGP		 mRNA:increased expression:liver (rat)
mRNA:increased expression:liver (human)
CTD Direct Evidence: marker/mechanism
OMIM:114550		 CTD
MouseDO
RGD		 PMID:9029167 PMID:12029619 PMID:15565109 PMID:29698666 PMID:21644509 More... RGD:6903288, RGD:7240567, RGD:7240695, RGD:7241004 NCBI chr15:61,857,190...61,862,210
Ensembl chr15:61,857,240...61,862,223 		JBrowse link
G Myd88 myeloid differentiation primary response gene 88 exacerbates
ameliorates
treatment		 ISO
IMP		 mRNA:increased expression:liver (human)
protein, mRNA:decreased expression:liver (human)
human cell line in a mouse model
protein:increased expression:liver (human)
mouse cell line in a mouse model
human gene and cell in a mouse model		 RGD PMID:29022910 PMID:28370778 PMID:17615358 PMID:33575076 PMID:32144747 More... RGD:150520022, RGD:150520169, RGD:150521532, RGD:150521534, RGD:150524327, RGD:150524329, RGD:150524330, RGD:150524334, RGD:150530285 NCBI chr 9:119,165,000...119,169,084
Ensembl chr 9:119,165,000...119,170,477 		JBrowse link
G Nat2 N-acetyltransferase 2 (arylamine N-acetyltransferase) ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 8:67,947,527...67,955,296
Ensembl chr 8:67,947,510...67,955,236 		JBrowse link
G Nbn nibrin ISO ClinVar Annotator: match by term: Hepatocellular cancer ClinVar PMID:9590180 PMID:9590181 PMID:9620777 PMID:10398434 PMID:10799436 More... NCBI chr 4:15,955,388...15,992,589
Ensembl chr 4:15,957,925...15,992,589 		JBrowse link
G Ncapg non-SMC condensin I complex, subunit G ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 5:45,827,212...45,858,491
Ensembl chr 5:45,827,261...45,857,888 		JBrowse link
G Ncaph non-SMC condensin I complex, subunit H ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:126,945,729...126,975,857
Ensembl chr 2:126,945,729...126,975,874 		JBrowse link
G Ncoa2 nuclear receptor coactivator 2 exacerbates IMP RGD PMID:28273073 PMID:22556267 RGD:153002573, RGD:153002576 NCBI chr 1:13,209,329...13,444,451
Ensembl chr 1:13,209,329...13,444,307 		JBrowse link
G Ndc80 NDC80 kinetochore complex component ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr17:71,803,095...71,833,852
Ensembl chr17:71,803,095...71,833,852 		JBrowse link
G Neil3 nei like 3 (E. coli) disease_progression ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:liver (human)		 CTD
RGD		 PMID:28284560 PMID:35693827 RGD:153344586 NCBI chr 8:54,039,902...54,092,100
Ensembl chr 8:54,039,902...54,092,100 		JBrowse link
G Nek2 NIMA (never in mitosis gene a)-related expressed kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:191,553,622...191,565,161
Ensembl chr 1:191,553,556...191,565,162 		JBrowse link
G Nf2 neurofibromin 2 disease_progression ISO DNA, protein:SNP, increased expression:intron, liver
protein:decreased expression:liver		 RGD PMID:29130106 PMID:27289045 PMID:26443326 RGD:150530489, RGD:150530504, RGD:11076529 NCBI chr11:4,715,845...4,799,544
Ensembl chr11:4,715,845...4,799,536 		JBrowse link
G Nfe2l1 nuclear factor, erythroid derived 2,-like 1 IAGP OMIM:114550 MouseDO NCBI chr11:96,708,239...96,720,810
Ensembl chr11:96,708,240...96,720,794 		JBrowse link
G Nfe2l2 nuclear factor, erythroid derived 2, like 2 ISO CTD Direct Evidence: marker/mechanism
ClinVar Annotator: match by term: Hepatocellular carcinoma		 CTD
ClinVar
RGD		 PMID:22561517 PMID:26619011 PMID:29018201 PMID:31546024 RGD:21201310 NCBI chr 2:75,505,860...75,535,007
Ensembl chr 2:75,505,857...75,534,985 		JBrowse link
G Nfkb1 nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105 disease_progression
treatment		 ISO associated with Chronic Hepatitis B;DNA:insertion/deletion:3'utr: -94ins/delATTG (rs28720239) (human) RGD PMID:19797428 PMID:25999787 RGD:40400751, RGD:152177911 NCBI chr 3:135,290,416...135,397,422
Ensembl chr 3:135,290,416...135,397,308 		JBrowse link
G Nfkbia nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha disease_progression
susceptibility		 ISO CTD Direct Evidence: therapeutic
associated with Chronic Hepatitis B;DNA:SNPs,haplotype:3'utr,promoter: 826C>T,881A>G (rs2233406,rs3138053) (human)
associated with hepatitis B;DNA:SNP:promoter:-826C>T (rs2233406) (human)		 CTD
RGD		 PMID:22022477 PMID:19797428 PMID:25223483 RGD:40400751, RGD:40902986 NCBI chr12:55,536,194...55,539,432
Ensembl chr12:55,536,195...55,539,432 		JBrowse link
G Nkx3-1 NK3 homeobox 1 treatment ISO mRNA:decreased expression:liver
human gene in a mouse model		 RGD PMID:28972178 PMID:28972178 RGD:14401599, RGD:14401599 NCBI chr14:69,428,141...69,432,107
Ensembl chr14:69,428,087...69,432,111 		JBrowse link
G Nlrc3 NLR family, CARD domain containing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30081150 NCBI chr16:3,762,871...3,796,881
Ensembl chr16:3,762,871...3,794,496 		JBrowse link
G Nlrc5 NLR family, CARD domain containing 5 ISO protein:increased expression:liver RGD PMID:27338800 RGD:15003194 NCBI chr 8:95,160,963...95,253,900
Ensembl chr 8:95,160,984...95,253,900 		JBrowse link
G Nme1 NME/NM23 nucleoside diphosphate kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21472284 NCBI chr11:93,849,751...93,859,341
Ensembl chr11:93,847,805...93,859,347 		JBrowse link
G Nnmt nicotinamide N-methyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 9:48,448,905...48,518,958
Ensembl chr 9:48,503,177...48,516,453 		JBrowse link
G Nos2 nitric oxide synthase 2, inducible treatment ISO RGD PMID:25999787 RGD:152177911 NCBI chr11:78,811,613...78,851,052
Ensembl chr11:78,811,613...78,851,080 		JBrowse link
G Notch3 notch 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr17:32,339,794...32,385,869
Ensembl chr17:32,339,794...32,385,826 		JBrowse link
G Nr0b2 nuclear receptor subfamily 0, group B, member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23811326 NCBI chr 4:133,280,687...133,283,997
Ensembl chr 4:133,280,687...133,283,847 		JBrowse link
G Nr1h2 nuclear receptor subfamily 1, group H, member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21147110 NCBI chr 7:44,199,040...44,204,928
Ensembl chr 7:44,199,040...44,203,375 		JBrowse link
G Nr1h4 nuclear receptor subfamily 1, group H, member 4 ISO
IAGP
IMP		 CTD Direct Evidence: marker/mechanism
OMIM:114550
mRNA:splice variant(s):liver (human)
intestinally expressed human gene in mouse model		 CTD
MouseDO
RGD		 PMID:23811326 PMID:25496033 PMID:23811326 PMID:23213087 PMID:24954587 RGD:14696796, RGD:14928330, RGD:14928334 NCBI chr10:89,290,096...89,369,484
Ensembl chr10:89,290,096...89,369,447 		JBrowse link
G Nras neuroblastoma ras oncogene disease_progression
severity		 ISO human gene in mouse model
mRNA, protein:increased expression:liver (mouse, human)
ClinVar Annotator: match by term: Hepatocellular cancer		 ClinVar
RGD		 PMID:1654209 PMID:2278970 PMID:2674680 PMID:3122217 PMID:6587382 More... RGD:14696775, RGD:14696793 NCBI chr 3:102,965,643...102,975,230
Ensembl chr 3:102,965,601...102,975,230 		JBrowse link
G Nrg1 neuregulin 1 disease_progression ISO associated with hepatitis C;mRNA:altered expression:liver (human
mRNA:increased expression:liver (human)		 RGD PMID:17393520 PMID:27514687 RGD:39456104, RGD:39456110 NCBI chr 8:32,299,493...33,381,858
Ensembl chr 8:32,304,579...33,374,825
Ensembl chr 8:32,304,579...33,374,825 		JBrowse link
G Nrp1 neuropilin 1 disease_progression ISO protein:decreased expression:liver RGD PMID:25333267 RGD:126848812 NCBI chr 8:129,085,553...129,231,957
Ensembl chr 8:129,085,085...129,229,844 		JBrowse link
G Nuf2 NUF2, NDC80 kinetochore complex component treatment
disease_progression		 ISO CTD Direct Evidence: marker/mechanism CTD
RGD		 PMID:28284560 PMID:30653265 PMID:31933938 RGD:28867240, RGD:28912742 NCBI chr 1:169,325,503...169,359,033
Ensembl chr 1:169,325,503...169,359,033 		JBrowse link
G Nusap1 nucleolar and spindle associated protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:119,449,205...119,480,646
Ensembl chr 2:119,448,779...119,481,725 		JBrowse link
G Oit3 oncoprotein induced transcript 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr10:59,258,782...59,277,601
Ensembl chr10:59,258,780...59,277,600 		JBrowse link
G Olfml2a olfactomedin-like 2A ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:38,821,992...38,850,597
Ensembl chr 2:38,821,990...38,853,765 		JBrowse link
G Olfml2b olfactomedin-like 2B ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 1:170,472,101...170,510,356
Ensembl chr 1:170,472,101...170,510,358 		JBrowse link
G Orc1 origin recognition complex, subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 4:108,436,651...108,472,030
Ensembl chr 4:108,436,620...108,472,030 		JBrowse link
G Otc ornithine transcarbamylase severity ISO mRNA:altered expression:liver tumor (human) RGD PMID:30901224 RGD:152995286 NCBI chr  X:10,118,584...10,187,275
Ensembl chr  X:10,118,544...10,187,263 		JBrowse link
G Pafah1b1 platelet-activating factor acetylhydrolase, isoform 1b, subunit 1 disease_progression ISO mRNA,protein:decreased expression:liver: RGD PMID:21569763 RGD:12790589 NCBI chr11:74,564,775...74,615,210
Ensembl chr11:74,564,775...74,615,496 		JBrowse link
G Pamr1 peptidase domain containing associated with muscle regeneration 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr 2:102,380,325...102,473,386
Ensembl chr 2:102,380,357...102,473,386 		JBrowse link
G Parp1 poly (ADP-ribose) polymerase family, member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18695907 NCBI chr 1:180,396,456...180,428,564
Ensembl chr 1:180,396,489...180,428,819 		JBrowse link
G Pbk PDZ binding kinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:28284560 NCBI chr14:66,043,337...66,055,271
Ensembl chr14:66,043,286...66,055,271 		JBrowse link
G Pck1 phosphoenolpyruvate carboxykinase 1, cytosolic ISO CTD Direct Evidence: marker/mechanism CTD PMID:19363144 PMID:28284560 NCBI chr 2:172,994,866...173,001,067
Ensembl chr 2:172,994,841...173,001,066 		JBrowse link
G Pclaf PCNA clamp associated factor